Skip to main content Accessibility help
×
Home
Hostname: page-component-768dbb666b-k9l4c Total loading time: 2.705 Render date: 2023-02-02T08:36:30.112Z Has data issue: true Feature Flags: { "useRatesEcommerce": false } hasContentIssue true

Chapter 3 - Histopathology of Liver Transplantation

Published online by Cambridge University Press:  17 March 2018

Phillip Ruiz
Affiliation:
University of Miami School of Medicine
Get access
Type
Chapter
Information
Publisher: Cambridge University Press
Print publication year: 2018

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Roberts, HW, Utuama, OA, Klevens, M, Teshale, E, Hughes, E, Jiles, R. The Contribution of Viral Hepatitis to the Burden of Chronic Liver Disease in the United States. The American Journal of Gastroenterology. 2014;109(3):387–93; quiz 6, 94.CrossRefGoogle ScholarPubMed
Asrani, SK, Larson, JJ, Yawn, B, Therneau, TM, Kim, WR. Underestimation of Liver-Related Mortality in the United States. Gastroenterology. 2013;145(2):375–82 e12.CrossRefGoogle ScholarPubMed
Kim, WR, Therneau, TM, Benson, JT, Kremers, WK, Rosen, CB, Gores, GJ, et al. Deaths on the Liver Transplant Waiting List: An Analysis of Competing Risks. Hepatology. 2006;43(2):345–51.CrossRefGoogle ScholarPubMed
Kim, WR, Lake, JR, Smith, JM, Skeans, MA, Schladt, DP, Edwards, EB, et al. OPTN/SRTR 2013 Annual Data Report: Liver. Am J Transplant. 2015;15 Suppl 2:128.CrossRefGoogle ScholarPubMed
Shukla, A, Vadeyar, H, Rela, M, Liver Transplantation, Shah S.: East versus West. J Clin Exp Hepatol. 2013;3(3):243–53.CrossRefGoogle ScholarPubMed
Fung, J. Management of Chronic Hepatitis B before and after Liver Transplantation. World J Hepatol. 2015;7(10):1421–6.CrossRefGoogle ScholarPubMed
Ghaziani, T, Sendi, H, Shahraz, S, Zamor, P, Bonkovsky, HL. Hepatitis B and Liver Transplantation: Molecular and Clinical Features that Influence Recurrence and Outcome. World J Gastroenterol. 2014;20(39):14142–55.CrossRefGoogle ScholarPubMed
Burra, P, De Martin, E, Zanetto, A, Senzolo, M, Russo, FP, Zanus, G, et al. HCV and Liver Transplantation: Where Do We Stand? Transpl Int. 2015.
Muir, AJ, Naggie, S. HCV Treatment: Is It Possible to Cure All HCV Patients? Clin Gastroenterol Hepatol. 2015.
Pipili, C, Cholongitas, E. Treatment of Chronic Hepatitis C in Liver Transplant Candidates and Recipients: Where Do We Stand? World J Hepatol. 2015;7(12):1606–16.CrossRefGoogle ScholarPubMed
Demetris, AJ, Zeevi, A, O’Leary, JG. ABO-compatible Liver Allograft Antibody-mediated Rejection: An Update. Curr Opin Organ Transplant. 2015;20(3):314–24.CrossRefGoogle ScholarPubMed
Demetris, AJ, Crawford, JM, Isse, K, Minervini, MI, Nalesnik, MA, Rubin, E, et al. Pathology of Liver and Hematopoietic Stem Cell Transplantation. In: Odze, RD, Goldblum, JR, editors. Surgical Pathology of the GI Tract, Liver, Biliary Tract and Pancreas 3rd ed. Philadelphia, PA: Elsevier/Saunders; 2015. p. 1408–61.Google Scholar
Demetris, AJ, Minervini, MI, Nalesnik, MA, Randhawa, P, Sasatomi, E. Histopathology of Liver Transplantation. In: Busuttil, RW, Klintmalm, GK, editors. Transplantation of the Liver 3rd ed. Philadelphia, PA: Elsevier/Saunders; 2015. p. 1112–70.Google Scholar
Demetris, AJ, Minervini, MI, Nalesnik, M, Rubin, E, Randhawa, P, Sasatomi, E. Histopathological Syndromes of Graft Rejection and Recurrent Disease: Liver. In: Kirk, A, Knechtle, S, Larsen, C, Pearson, T, Madsen, J, Webber, S, editors. Textbook of Organ Transplantation. Hoboken, NJ: Wiley-Blackwell; 2014. p. 927–56.Google Scholar
Demetris, AJ, Minervini, MI, Nalesnik, MA, Randhawa, PS, Sasatomi, E. Liver Transplantation. In: McManus, LM, Mitchell, R, editors. Pathobiology of Human Disease: A Dynamic Encyclopedia of Disease Mechanisms. San Diego, CA: Elsevier; 2014. p. 676–93.Google Scholar
Starzl, TE, Marchioro, TL, Von Kaulla, KN, Hermann, G, Brittain, RS, Waddell, WR. Homotransplantation of the Liver in Humans. Surg Gynecol Obstet. 1963;117:659–76.Google ScholarPubMed
Merion, RM, Goodrich, NP, Feng, S. How Can We Define Expanded Criteria for Liver Donors? Journal of Hepatology. 2006;45(4):484–8.CrossRefGoogle ScholarPubMed
McCormack, L, Dutkowski, P, El-Badry, AM, Clavien, PA. Liver Transplantation Using Fatty Livers: Always Feasible? Journal of Hepatology. 2011;54(5):1055–62.CrossRefGoogle ScholarPubMed
Op den Dries, S, Sutton, ME, Lisman, T, Porte, RJ. Protection of Bile Ducts in Liver Transplantation: Looking beyond Ischemia. Transplantation. 2011;92(4):373–9.CrossRefGoogle ScholarPubMed
Fontes, P, Lopez, R, van der Plaats, A, Vodovotz, Y, Minervini, M, Scott, V, et al. Liver Preservation with Machine Perfusion and a Newly Developed Cell-free Oxygen Carrier Solution under Subnormothermic Conditions. Am J Transplant. 2015;15(2):381–94.CrossRefGoogle Scholar
Orman, ES, Mayorga, ME, Wheeler, SB, Townsley, RM, Toro-Diaz, HH, Hayashi, PH, et al. Declining Liver Graft Quality Threatens the Future of Liver Transplantation in the United States. Liver Transpl. 2015;21(8):1040–50.CrossRefGoogle ScholarPubMed
Orman, ES, ASt, Barritt, Wheeler, SB, Hayashi, PH. Declining Liver Utilization for Transplantation in the United States and the Impact of Donation after Cardiac Death. Liver Transpl. 2013;19(1):5968.CrossRefGoogle ScholarPubMed
Weeder, PD, van Rijn, R, Porte, RJ. Machine Perfusion in Liver Transplantation as a Tool to Prevent Non-anastomotic Biliary Strictures: Rationale, Current Evidence and Future Directions. Journal of Hepatology. 2015;63(1):265–75.CrossRefGoogle ScholarPubMed
Foley, DP, Fernandez, LA, Leverson, G, Anderson, M, Mezrich, J, Sollinger, HW, et al. Biliary Complications after Liver Transplantation from Donation after Cardiac Death Donors: An Analysis of Risk Factors and Long-term Outcomes from a Single Center. Ann Surg. 2011;253(4):817–25.CrossRefGoogle ScholarPubMed
Abt, P, Crawford, M, Desai, N, Markmann, J, Olthoff, K, Shaked, A. Liver Transplantation from Controlled Non-Heart-Beating Donors: An Increased Incidence of Biliary Complications. Transplantation. 2003;75(10):1659–63.CrossRefGoogle ScholarPubMed
Jay, CL, Lyuksemburg, V, Ladner, DP, Wang, E, Caicedo, JC, Holl, JL, et al. Ischemic Cholangiopathy after Controlled Donation after Cardiac Death Liver Transplantation: A Meta-analysis. Ann Surg. 2011;253(2):259–64.CrossRefGoogle ScholarPubMed
Schlegel, A, Dutkowski, P. Role of Hypothermic Machine Perfusion in Liver Transplantation. Transpl Int. 2015;28(6):677–89.CrossRefGoogle ScholarPubMed
Liu, Q, Nassar, A, Farias, K, Buccini, L, Baldwin, W, Mangino, M, et al. Sanguineous Normothermic Machine Perfusion Improves Hemodynamics and Biliary Epithelial Regeneration in Donation after Cardiac Death Porcine Livers. Liver Transpl. 2014;20(8):987–99.CrossRefGoogle ScholarPubMed
Ravikumar, R, Leuvenink, H, Friend, PJ. Normothermic Liver Preservation: A New Paradigm? Transpl Int. 2015;28(6):690–9.CrossRefGoogle ScholarPubMed
Slieker, JC, Farid, WR, van Eijck, CH, Lange, JF, van Bommel, J, Metselaar, HJ, et al. Significant Contribution of the Portal Vein to Blood Flow through the Common Bile Duct. Ann Surg. 2012;255(3):523–7.CrossRefGoogle ScholarPubMed
Barrou, B, Billault, C, Nicolas-Robin, A. The Use of Extracorporeal Membranous Oxygenation in Donors after Cardiac Death. Curr Opin Organ Transplant. 2013;18(2):148–53.CrossRefGoogle ScholarPubMed
Karimian, N, Op den Dries, S, Porte, RJ. The Origin of Biliary Strictures after Liver Transplantation: Is It the Amount of Epithelial Injury or Insufficient Regeneration that Counts? Journal of Hepatology. 2013;58(6):1065–7.CrossRefGoogle ScholarPubMed
Boehnert, MU, Yeung, JC, Bazerbachi, F, Knaak, JM, Selzner, N, McGilvray, ID, et al. Normothermic Acellular ex Vivo Liver Perfusion Reduces Liver and Bile Duct Injury of Pig Livers Retrieved after Cardiac Death. Am J Transplant. 2013;13(6):1441–9.Google ScholarPubMed
Brunner, SM, Junger, H, Ruemmele, P, Schnitzbauer, AA, Doenecke, A, Kirchner, GI, et al. Bile Duct Damage after Cold Storage of Deceased Donor Livers Predicts Biliary Complications after Liver Transplantation. Journal of Hepatology. 2013;58(6):1133–9.CrossRefGoogle ScholarPubMed
Hansen, T, Hollemann, D, Pitton, MB, Heise, M, Hoppe-Lotichius, M, Schuchmann, M, et al. Histological Examination and Evaluation of Donor Bile Ducts Received during Orthotopic Liver Transplantation–A Morphological Clue to Ischemic-type Biliary Lesion? Virchows Arch. 2012;461(1):41–8.CrossRefGoogle ScholarPubMed
Op den Dries, S, Westerkamp, AC, Karimian, N, Gouw, AS, Bruinsma, BG, Markmann, JF, et al. Injury to Peribiliary Glands and Vascular Plexus before Liver Transplantation Predicts Formation of Non-anastomotic Biliary Strictures. Journal of Hepatology. 2014.
Karimian, N, Westerkamp, AC, Porte, RJ. Biliary Complications after Orthotopic Liver Transplantation. Curr Opin Organ Transplant. 2014;19(3):209–16.CrossRefGoogle ScholarPubMed
Karimian, N, Weeder, PD, Bomfati, F, Gouw, AS, Porte, RJ. Preservation Injury of the Distal Extrahepatic Bile Duct of Donor Livers Is Representative for Injury of the Intrahepatic Bile Ducts. Journal of Hepatology. 2015;63(1):284–7.CrossRefGoogle ScholarPubMed
Clavien, PA, Harvey, PR, Strasberg, SM. Preservation and Reperfusion Injuries in Liver Allografts. An Overview and Synthesis of Current Studies. Transplantation. 1992;53(5):957–78.CrossRefGoogle ScholarPubMed
Schon, MR, Kollmar, O, Wolf, S, Schrem, H, Matthes, M, Akkoc, N, et al. Liver Transplantation after Organ Preservation with Normothermic Extracorporeal Perfusion. Ann Surg. 2001;233(1):114–23.CrossRefGoogle ScholarPubMed
Friend, PJ, Imber, C, St Peter, S, Lopez, I, Butler, AJ, Rees, MA. Normothermic Perfusion of the Isolated Liver. Transplantation Proceedings. 2001;33(7–8):3436–8.CrossRefGoogle ScholarPubMed
Butler, AJ, Rees, MA, Wight, DG, Casey, ND, Alexander, G, White, DJ, et al. Successful Extracorporeal Porcine Liver Perfusion for 72 Hr. Transplantation. 2002;73(8):1212–8.CrossRefGoogle ScholarPubMed
Imber, CJ, St Peter, SD, Lopez de Cenarruzabeitia, I, Pigott, D, James, T, Taylor, R, et al. Advantages of Normothermic Perfusion over Cold Storage in Liver Preservation. Transplantation. 2002;73(5):701–9.CrossRefGoogle ScholarPubMed
Reddy, S, Greenwood, J, Maniakin, N, Bhattacharjya, S, Zilvetti, M, Brockmann, J, et al. Non-Heart-Beating Donor Porcine Livers: The Adverse Effect of Cooling. Liver Transpl. 2005;11(1):35–8.CrossRefGoogle ScholarPubMed
Boehnert, MU, Yeung, JC, Knaak, JM, Selzner, N, Selzner, M. Normothermic Acellular ex Vivo Liver Perfusion (NEVLP) Reduces Liver and Bile Duct in DCD Liver Grafts. Am J Transplant. 2013;13(12):3290.CrossRefGoogle ScholarPubMed
Sutton, ME, op den Dries, S, Karimian, N, Weeder, PD, de Boer, MT, Wiersema-Buist, J, et al. Criteria for Viability Assessment of Discarded Human Donor Livers during ex Vivo Normothermic Machine Perfusion. PLoS One. 2014;9(11):e110642.CrossRefGoogle ScholarPubMed
Guarrera, JV, Henry, SD, Samstein, B, Reznik, E, Musat, C, Lukose, TI, et al. Hypothermic Machine Preservation Facilitates Successful Transplantation of “Orphan” Extended Criteria Donor Livers. Am J Transplant. 2015;15(1):161–9.CrossRefGoogle ScholarPubMed
Dutkowski, P, Furrer, K, Tian, Y, Graf, R, Clavien, PA. Novel Short-term Hypothermic Oxygenated Perfusion (HOPE) System Prevents Injury in Rat Liver Graft from Non-Heart Beating Donor. Ann Surg. 2006;244(6):968–76; discussion 76–7.CrossRefGoogle ScholarPubMed
Schlegel, A, Graf, R, Clavien, PA, Dutkowski, P. Hypothermic Oxygenated Perfusion (HOPE) Protects from Biliary Injury in a Rodent Model of DCD Liver Transplantation. Journal of Hepatology. 2013;59(5):984–91.CrossRefGoogle Scholar
Op den Dries, S, Sutton, ME, Karimian, N, de Boer, MT, Wiersema-Buist, J, Gouw, AS, et al. Hypothermic Oxygenated Machine Perfusion Prevents Arteriolonecrosis of the Peribiliary Plexus in Pig Livers Donated after Circulatory Death. PLoS One. 2014;9(2):e88521.CrossRefGoogle Scholar
Berendsen, TA, Bruinsma, BG, Lee, J, D’Andrea, V, Liu, Q, Izamis, ML, et al. A Simplified Subnormothermic Machine Perfusion System Restores Ischemically Damaged Liver Grafts in a Rat Model of Orthotopic Liver Transplantation. Transplantation Research. 2012;1(1):6.CrossRefGoogle Scholar
Bruinsma, BG, Yeh, H, Ozer, S, Martins, PN, Farmer, A, Wu, W, et al. Subnormothermic Machine Perfusion for ex Vivo Preservation and Recovery of the Human Liver for Transplantation. Am J Transplant. 2014;14(6):1400–9.CrossRefGoogle ScholarPubMed
Tolboom, H, Izamis, ML, Sharma, N, Milwid, JM, Uygun, B, Berthiaume, F, et al. Subnormothermic Machine Perfusion at Both 20 Degrees C and 30 Degrees C Recovers Ischemic Rat Livers for Successful Transplantation. J Surg Res. 2012;175(1):149–56.CrossRefGoogle Scholar
Knaak, JM, Spetzler, VN, Goldaracena, N, Boehnert, MU, Bazerbachi, F, Louis, KS, et al. Subnormothermic ex Vivo Liver Perfusion Reduces Endothelial Cell and Bile Duct Injury after Donation after Cardiac Death Pig Liver Transplantation. Liver Transpl. 2014;20(11):1296–305.CrossRefGoogle ScholarPubMed
Routh, D, Naidu, S, Sharma, S, Ranjan, P, Godara, R. Changing Pattern of Donor Selection Criteria in Deceased Donor Liver Transplant: A Review of Literature. J Clin Exp Hepatol. 2013;3(4):337–46.CrossRefGoogle ScholarPubMed
Harring, TR, O’Mahony, CA, Goss, JA. Extended Donors in Liver Transplantation. Clinics in Liver Disease. 2011;15(4):879900.CrossRefGoogle ScholarPubMed
Nickkholgh, A, Weitz, J, Encke, J, Sauer, P, Mehrabi, A, Büchler, MW, et al. Utilization of Extended Donor Criteria in Liver Transplantation: A Comprehensive Review of the Literature. Nephrol Dial Transplant. 2007;22 Suppl 8:viii29viii36.CrossRefGoogle ScholarPubMed
Busuttil, RW, Tanaka, K. The Utility of Marginal Donors in Liver Transplantation. Liver Transpl. 2003;9(7):651–63.CrossRefGoogle ScholarPubMed
Alkofer, B, Samstein, B, Guarrera, JV, Kin, C, Jan, D, Bellemare, S, et al. Extended-donor Criteria Liver Allografts. Seminars in Liver Disease. 2006;26(3):221–33.CrossRefGoogle ScholarPubMed
Feng, S, Goodrich, NP, Bragg-Gresham, JL, Dykstra, DM, Punch, JD, DebRoy, MA, et al. Characteristics Associated with Liver Graft Failure: The Concept of a Donor Risk Index. Am J Transplant. 2006;6(4):783–90.CrossRefGoogle ScholarPubMed
Nalesnik, MA, Woodle, ES, Dimaio, JM, Vasudev, B, Teperman, LW, Covington, S, et al. Donor-transmitted Malignancies in Organ Transplantation: Assessment of Clinical Risk. American Journal of Transplantation: Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 2011;11(6):1140–7.CrossRefGoogle ScholarPubMed
Ison, MG, Nalesnik, MA. An Update on Donor-derived Disease Transmission in Organ Transplantation. American Journal of Transplantation: Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 2011;11(6):1123–30.CrossRefGoogle ScholarPubMed
Green, M, Covington, S, Taranto, S, Wolfe, C, Bell, W, Biggins, SW, et al. Donor-derived Transmission Events in 2013: A Report of the Organ Procurement Transplant Network Ad Hoc Disease Transmission Advisory Committee. Transplantation. 2015;99(2):282–7.CrossRefGoogle ScholarPubMed
Reich, DJ, Mulligan, DC, Abt, PL, Pruett, TL, Abecassis, MM, D’Alessandro, A, et al. ASTS Recommended Practice Guidelines for Controlled Donation after Cardiac Death Organ Procurement and Transplantation. Am J Transplant. 2009;9(9):2004–11.CrossRefGoogle ScholarPubMed
Todo, S, Demetris, AJ, Makowka, L, Teperman, L, Podesta, L, Shaver, T, et al. Primary Nonfunction of Hepatic Allografts with Preexisting Fatty Infiltration. Transplantation. 1989;47(5):903–5.CrossRefGoogle ScholarPubMed
Kakizoe, S, Yanaga, K, Starzl, TE, Demetris, AJ. Frozen Section of Liver Biopsy for the Evaluation of Liver Allografts. Transplant Proc. 1990;22(2):416–7.Google ScholarPubMed
Zamboni, F, Franchello, A, David, E, Rocca, G, Ricchiuti, A, Lavezzo, B, et al. Effect of Macrovescicular Steatosis and Other Donor and Recipient Characteristics on the Outcome of Liver Transplantation. Clin Transplant. 2001;15(1):53–7.CrossRefGoogle ScholarPubMed
Spitzer, AL, Lao, OB, Dick, AA, Bakthavatsalam, R, Halldorson, JB, Yeh, MM, et al. The Biopsied Donor Liver: Incorporating Macrosteatosis into High-risk Donor Assessment. Liver Transpl. 2010;16(7):874–84.CrossRefGoogle ScholarPubMed
Sharkey, FE, Lytvak, I, Prihoda, TJ, Speeg, KV, Washburn, WK, Halff, GA. High-grade Microsteatosis and Delay in Hepatic Function after Orthotopic Liver Transplantation. Human Pathology. 2011;42(9):1337–42.CrossRefGoogle ScholarPubMed
Fiorini, RN, Kirtz, J, Periyasamy, B, Evans, Z, Haines, JK, Cheng, G, et al. Development of an Unbiased Method for the Estimation of Liver Steatosis. Clin Transplant. 2004;18(6):700–6.CrossRefGoogle ScholarPubMed
D’Alessandro, AM, Kalayoglu, M, Sollinger, HW, Hoffmann, RM, Reed, A, Knechtle, SJ, et al. The Predictive Value of Donor Liver Biopsies for the Development of Primary Nonfunction after Orthotopic Liver Transplantation. Transplantation. 1991;51(1):157–63.CrossRefGoogle ScholarPubMed
McCormack, L, Petrowsky, H, Jochum, W, Mullhaupt, B, Weber, M, Clavien, PA. Use of Severely Steatotic Grafts in Liver Transplantation: A Matched Case-control Study. Ann Surg. 2007;246(6):940–6; discussion 68.CrossRefGoogle ScholarPubMed
Angele, MK, Rentsch, M, Hartl, WH, Wittmann, B, Graeb, C, Jauch, KW, et al. Effect of Graft Steatosis on Liver Function and Organ Survival after Liver Transplantation. Am J Surg. 2008;195(2):214–20.CrossRefGoogle ScholarPubMed
D’Alessandro, E, Calabrese, F, Gringeri, E, Valente, M. Frozen-section Diagnosis in Donor Livers: Error Rate Estimation of Steatosis Degree. Transplantation Proceedings. 2010;42(6):2226–8.Google ScholarPubMed
Fiorentino, M, Vasuri, F, Ravaioli, M, Ridolfi, L, Grigioni, WF, Pinna, AD, et al. Predictive Value of Frozen-section Analysis in the Histological Assessment of Steatosis before Liver Transplantation. Liver Transpl. 2009;15(12):1821–5.CrossRefGoogle ScholarPubMed
Chen, CL, Cheng, YF, Yu, CY, Ou, HY, Tsang, LL, Huang, TL, et al. Living Donor Liver Transplantation: The Asian Perspective. Transplantation. 2014;97 Suppl 8:S3.CrossRefGoogle ScholarPubMed
Markin, RS, Wisecarver, JL, Radio, SJ, Stratta, RJ, Langnas, AN, Hirst, K, et al. Frozen Section Evaluation of Donor Livers before Transplantation. Transplantation. 1993;56(6):1403–9.CrossRefGoogle ScholarPubMed
Patwardhan, VR, Curry, MP. Reappraisal of the Hepatitis C Virus-positive Donor in Solid Organ Transplantation. Curr Opin Organ Transplant. 2015;20(3):267–75.CrossRefGoogle ScholarPubMed
Ballarin, R, Cucchetti, A, Spaggiari, M, Montalti, R, Di Benedetto, F, Nadalin, S, et al. Long-term Follow-up and Outcome of Liver Transplantation from Anti-hepatitis C virus-positive Donors: A European Multicentric Case-control Study. Transplantation. 2011;91(11):1265–72.CrossRefGoogle ScholarPubMed
Dodson, SF, Issa, S, Araya, V, Gayowski, T, Pinna, A, Eghtesad, B, et al. Infectivity of Hepatic Allografts with Antibodies to Hepatitis B Virus. Transplantation. 1997;64(11):1582–4.CrossRefGoogle ScholarPubMed
Avelino-Silva, VI, D’Albuquerque, LA, Bonazzi, PR, Song, AT, Miraglia, JL, De Brito Neves, A, et al. Liver Transplant from Anti-HBc-positive, HBsAg-negative Donor into HBsAg-negative Recipient: Is It Safe? A Systematic Review of the Literature. Clin Transplant. 2010;24(6):735–46.CrossRefGoogle Scholar
Adams, D, Lacroix, C, Antonini, T, Lozeron, P, Denier, C, Kreib, AM, et al. Symptomatic and Proven de Novo Amyloid Polyneuropathy in Familial Amyloid Polyneuropathy Domino Liver Recipients. Amyloid. 2011;18 Suppl 1:169–72.CrossRefGoogle ScholarPubMed
Aziz, S, Callen, PW, Vincenti, F, Hirose, R. Rapidly Developing Nephrocalcinosis in a Patient with End-stage Liver Disease Who Received a Domino Liver Transplant from a Patient with Known Congenital Oxalosis. J Ultrasound Med. 2005;24(10):1449–52.CrossRefGoogle Scholar
Lee, SM, Speeg, KV, Pollack, MS, Sharkey, FE. Progression of Morphological Changes after Transplantation of a Liver with Heterozygous Alpha-1 Antitrypsin Deficiency. Human Pathology. 2011.
Tanaka, K, Kiuchi, T. Living-donor Liver Transplantation in the New Decade: Perspective from the Twentieth to the Twenty-first Century. J Hepatobiliary Pancreat Surg. 2002;9(2):218–22.CrossRefGoogle ScholarPubMed
Song, GW, Lee, SG. Living Donor Liver Transplantation. Curr Opin Organ Transplant. 2014;19(3):217–22.Google ScholarPubMed
Cheah, YL, Simpson, MA, Pomposelli, JJ, Pomfret, EA. Incidence of Death and Potentially Life-threatening Near-miss Events in Living Donor Hepatic Lobectomy: A World-wide Survey. Liver Transpl. 2013;19(5):499506.CrossRefGoogle ScholarPubMed
Nadalin, S, Malago, M, Valentin-Gamazo, C, Testa, G, Baba, HA, Liu, C, et al. Preoperative Donor Liver Biopsy for Adult Living Donor Liver Transplantation: Risks and Benefits. Liver Transpl. 2005;11(8):980–6.CrossRefGoogle ScholarPubMed
Tran, TT, Changsri, C, Shackleton, CR, Poordad, FF, Nissen, NN, Colquhoun, S, et al. Living Donor Liver Transplantation: Histological Abnormalities Found on Liver Biopsies of Apparently Healthy Potential Donors. J Gastroenterol Hepatol. 2006;21(2):381–3.CrossRefGoogle ScholarPubMed
Ryan, CK, Johnson, LA, Germin, BI, Marcos, A. One Hundred Consecutive Hepatic Biopsies in the Workup of Living Donors for Right Lobe Liver Transplantation. Liver Transpl. 2002;8(12):1114–22.CrossRefGoogle ScholarPubMed
Trotter, JF, Wachs, M, Everson, GT, Kam, I. Adult-to-Adult Transplantation of the Right Hepatic Lobe from a Living Donor. The New England Journal of Medicine. 2002;346(14):1074–82.CrossRefGoogle ScholarPubMed
Simpson, MA, Pomfret, EA. Checking the Harness: Safety for Living Liver Donors. Liver Transpl. 2012;18 Suppl 2:S159.CrossRefGoogle ScholarPubMed
Minervini, MI, Ruppert, K, Fontes, P, Volpes, R, Vizzini, G, de Vera, ME, et al. Liver Biopsy Findings from Healthy Potential Living Liver Donors: Reasons for Disqualification, Silent Diseases and Correlation with Liver Injury Tests. Journal of Hepatology. 2009;50(3):501–10.CrossRefGoogle ScholarPubMed
Lee, JY, Kim, KM, Lee, SG, Yu, E, Lim, YS, Lee, HC, et al. Prevalence and Risk Factors of Non-alcoholic Fatty Liver Disease in Potential Living Liver Donors in Korea: A Review of 589 Consecutive Liver Biopsies in a Single Center. Journal of Hepatology. 2007;47(2):239–44.CrossRefGoogle Scholar
Rinella, ME, Alonso, E, Rao, S, Whitington, P, Fryer, J, Abecassis, M, et al. Body Mass Index as a Predictor of Hepatic Steatosis in Living Liver Donors. Liver Transpl. 2001;7(5):409–14.CrossRefGoogle ScholarPubMed
Fan, ST, Lo, CM, Liu, CL, Yong, BH, Chan, JK, Ng, IO. Safety of Donors in Live Donor Liver Transplantation Using Right Lobe Grafts. Archives of Surgery. 2000;135(3):336–40.CrossRefGoogle ScholarPubMed
Dorwal, P, Gautam, D, Sharma, D, Singh, DR, Raina, V. Donor Biopsy in Living Donor Liver Transplantation: Is It Still Relevant in a Developing Country? Malays J Pathol. 2015;37(1):3943.Google Scholar
Starzl, TE. History of Liver and Other Splanchnic Organ Transplantation. In: Busuttil, R, Klintmalm, G, editors. Transplantation of the Liver. Philadelphia: W.B. Saunders Company; 1996. p. 322.Google Scholar
Rockey, DC, Caldwell, SH, Goodman, ZD, Nelson, RC, Smith, AD. Liver Biopsy. Hepatology. 2009;49(3):1017–44.CrossRefGoogle ScholarPubMed
Pathology, BWGoLA. Importance of Liver Biopsy Findings in Immunosuppression Management: Biopsy Monitoring and Working Criteria for Patients with Operational Tolerance. Liver Transpl. 2012;18(10):1154–70.Google Scholar
Bellizzi, AM, LeGallo, RD, Boyd, JC, Iezzoni, JC. Hepatocyte Cytokeratin 7 Expression in Chronic Allograft Rejection. Am J Clin Pathol. 2011;135(2):238–44.CrossRefGoogle ScholarPubMed
Demetris, AJ, Jaffe, R, Starzl, TE. A Review of Adult and Pediatric Post-transplant Liver Pathology. Pathol Annu. 1987;22(Pt 2):347–86.Google ScholarPubMed
Sieders, E, Peeters, PM, TenVergert, EM, de Jong, KP, Porte, RJ, Zwaveling, JH, et al. Graft Loss after Pediatric Liver Transplantation. Annals of Surgery. 2002;235(1):125–32.CrossRefGoogle ScholarPubMed
Kashyap, R, Jain, A, Reyes, J, Demetris, AJ, Elmagd, KA, Dodson, SF, et al. Causes of Retransplantation after Primary Liver Transplantation in 4000 Consecutive Patients: 2 to 19 Years Follow-up. Transplantation Proceedings. 2001;33(1–2):1486–7.Google ScholarPubMed
Jain, A, Reyes, J, Kashyap, R, Dodson, SF, Demetris, AJ, Ruppert, K, et al. Long-term Survival after Liver Transplantation in 4,000 Consecutive Patients at a Single Center. Ann Surg. 2000;232(4):490500.CrossRefGoogle Scholar
Rabkin, JM, de La Melena, V, Orloff, SL, Corless, CL, Rosen, HR, Olyaei, AJ. Late Mortality after Orthotopic Liver Transplantation. Am J Surg. 2001;181(5):475–9.CrossRefGoogle ScholarPubMed
Kitchens, WH, Yeh, H, Markmann, JF. Hepatic Retransplant: What Have We Learned? Clin Liver Dis. 2014;18(3):731–51.CrossRefGoogle ScholarPubMed
Jain, A, Demetris, AJ, Kashyap, R, Blakomer, K, Ruppert, K, Khan, A, et al. Does Tacrolimus Offer Virtual Freedom from Chronic Rejection after Primary Liver Transplantation? Risk and Prognostic Factors in 1,048 Liver Transplantations with a Mean Follow-up of 6 Years. Liver Transpl. 2001;7(7):623–30.CrossRefGoogle ScholarPubMed
McCashland, T, Watt, K, Lyden, E, Adams, L, Charlton, M, Smith, AD, et al. Retransplantation for Hepatitis C: Results of a U.S. Multicenter Retransplant Study. Liver Transpl. 2007;13(9):1246–53.CrossRefGoogle Scholar
Kim, KR, Ko, GY, Sung, KB, Yoon, HK, Shin, JH, Song, HY, et al. Transjugular Liver Biopsy in Patients with Living Donor Liver Transplantation: Comparison with Percutaneous Biopsy. Liver Transplantation: Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society. 2008;14(7):971–9.CrossRefGoogle ScholarPubMed
Astarcioglu, I, Cursio, R, Reynes, M, Gugenheim, J. Increased Risk of Antibody-mediated Rejection of Reduced-size Liver Allografts. J Surg Res. 1999;87(2):258–62.CrossRefGoogle ScholarPubMed
Demetris, AJ, Kelly, DM, Eghtesad, B, Fontes, P, Wallis Marsh, J, Tom, K, et al. Pathophysiologic Observations and Histopathologic Recognition of the Portal Hyperperfusion or Small-for-Size Syndrome. Am J Surg Pathol. 2006;30(8):986–93.CrossRefGoogle ScholarPubMed
Peralta, C, Jiménez-Castro, MB, Gracia-Sancho, J. Hepatic Ischemia and Reperfusion Injury: Effects on the Liver Sinusoidal Milieu. Journal of Hepatology. 2013;59(5):1094–106.CrossRefGoogle ScholarPubMed
Zhai, Y, Petrowsky, H, Hong, JC, Busuttil, RW, Kupiec-Weglinski, JW. Ischaemia-Reperfusion Injury in Liver Transplantation–From Bench to Bedside. Nat Rev Gastroenterol Hepatol. 2013;10(2):7989.CrossRefGoogle Scholar
Hong, JC, Yersiz, H, Kositamongkol, P, Xia, VW, Kaldas, FM, Petrowsky, H, et al. Liver Transplantation Using Organ Donation after Cardiac Death: A Clinical Predictive Index for Graft Failure-free Survival. Arch Surg. 2011;146(9):1017–23.CrossRefGoogle ScholarPubMed
de Vera, ME, Lopez-Solis, R, Dvorchik, I, Campos, S, Morris, W, Demetris, AJ, et al. Liver Transplantation Using Donation after Cardiac Death Donors: Long-term Follow-up from a Single Center. Am J Transplant. 2009;9(4):773–81.CrossRefGoogle ScholarPubMed
Taner, CB, Bulatao, IG, Willingham, DL, Perry, DK, Sibulesky, L, Pungpapong, S, et al. Events in Procurement as Risk Factors for Ischemic Cholangiopathy in Liver Transplantation Using Donation after Cardiac Death Donors. Liver Transpl. 2012;18(1):100–11.CrossRefGoogle ScholarPubMed
Kakizoe, S, Yanaga, K, Starzl, TE, Demetris, AJ. Evaluation of Protocol before Transplantation and after Reperfusion Biopsies from Human Orthotopic Liver Allografts: Considerations of Preservation and Early Immunological Injury. Hepatology. 1990;11(6):932–41.CrossRefGoogle ScholarPubMed
Ludwig, J, Batts, KP, MacCarty, RL. Ischemic Cholangitis in Hepatic Allografts. Mayo Clinic Proceedings. 1992;67(6):519–26.CrossRefGoogle ScholarPubMed
Cameron, AM, Busuttil, RW. Ischemic Cholangiopathy after Liver Transplantation. Hepatobiliary Pancreat Dis Int. 2005;4(4):495501.Google ScholarPubMed
Kocbiyik, A, Demirhan, B, Sevmis, S, Budakoglu, I, Karakayali, H, Haberal, M. Role of Postreperfusion Subcapsular Wedge Biopsies in Predicting Initially Poor Graft Function after Liver Transplantation. Transplantation Proceedings. 2009;41(7):2747–8.CrossRefGoogle ScholarPubMed
Ali, JM, Davies, SE, Brais, RJ, Randle, LV, Klinck, JR, Allison, ME, et al. Analysis of Ischemia/Reperfusion Injury in Time-zero Biopsies Predicts Liver Allograft Outcomes. Liver Transpl. 2015;21(4):487–99.CrossRefGoogle ScholarPubMed
Shahbazi, N, Haeri, H, Nasiri Toosi, M, Jafarian, A, Shahsiah, R, Talebian Moghadam, M, et al. Correlation of Histopathologic Findings of Non-graft Threatening Preservation/Reperfusion Injury in Time-zero Liver Needle Biopsies With Short-term Post-transplantation Laboratory Alterations. Hepat Mon. 2015;15(6):e30008.CrossRefGoogle ScholarPubMed
Kukan, M, Haddad, PS. Role of Hepatocytes and Bile Duct Cells in Preservation-Reperfusion Injury of Liver Grafts. Liver Transpl. 2001;7(5):381400.CrossRefGoogle ScholarPubMed
Lunz, J, Ruppert, KM, Cajaiba, MM, Isse, K, Bentlejewski, CA, Minervini, M, et al. Re-examination of the Lymphocytotoxic Crossmatch in Liver Transplantation: Can C4d Stains Help in Monitoring? American Journal of Transplantation: Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 2012;12(1):171–82.CrossRefGoogle ScholarPubMed
Dahm, F, Georgiev, P, Clavien, PA. Small-for-Size Syndrome after Partial Liver Transplantation: Definition, Mechanisms of Disease and Clinical Implications. American Journal of Transplantation: Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 2005;5(11):2605–10.CrossRefGoogle ScholarPubMed
Chan, SC, Lo, CM, Fan, ST. Simplifying Living Donor Liver Transplantation. Hepatobiliary & Pancreatic Diseases International: HBPD INT. 2010;9(1):914.Google ScholarPubMed
Chan, SC, Lo, CM, Ng, KK, Ng, IO, Yong, BH, Fan, ST. Portal Inflow and Pressure Changes in Right Liver Living Donor Liver Transplantation Including the Middle Hepatic Vein. Liver Transpl. 2011;17(2):115–21.CrossRefGoogle ScholarPubMed
Man, K, Fan, ST, Lo, CM, Liu, CL, Fung, PC, Liang, TB, et al. Graft Injury in Relation to Graft Size in Right Lobe Live Donor Liver Transplantation: A Study of Hepatic Sinusoidal Injury in Correlation with Portal Hemodynamics and Intragraft Gene Expression. Ann Surg. 2003;237(2):256–64.CrossRefGoogle ScholarPubMed
Lautt, WW. Mechanism and Role of Intrinsic Regulation of Hepatic Arterial Blood Flow: Hepatic Arterial Buffer Response. Am J Physiol. 1985;249(5 Pt 1):G54956.Google ScholarPubMed
Eipel, C, Abshagen, K, Vollmar, B. Regulation of Hepatic Blood Flow: The Hepatic Arterial Buffer Response Revisited. World J Gastroenterol. 2010;16(48):6046–57.CrossRefGoogle ScholarPubMed
Kelly, DM, Zhu, X, Shiba, H, Irefin, S, Trenti, L, Cocieru, A, et al. Adenosine Restores the Hepatic Artery Buffer Response and Improves Survival in a Porcine Model of Small-for-Size Syndrome. Liver Transpl. 2009;15(11):1448–57.CrossRefGoogle Scholar
Botha, JF, Langnas, AN, Campos, BD, Grant, WJ, Freise, CE, Ascher, NL, et al. Left Lobe Adult-to-Adult Living Donor Liver Transplantation: Small Grafts and Hemiportocaval Shunts in the Prevention of Small-for-Size Syndrome. Liver Transpl. 2010;16(5):649–57.Google ScholarPubMed
Michalopoulos, GK. Principles of Liver Regeneration and Growth Homeostasis. Compr Physiol. 2013;3(1):485513.Google ScholarPubMed
Starzl, TE, Fung, JJ. Themes of Liver Transplantation. Hepatology. 2010;51(6):1869–84.CrossRefGoogle ScholarPubMed
Hessheimer, AJ, Fondevila, C, Taura, P, Munoz, J, Sanchez, O, Fuster, J, et al. Decompression of the Portal Bed and Twice-baseline Portal Inflow are Necessary for the Functional Recovery of a “Small-for-Size” Graft. Annals of Surgery. 2011;253(6):1201–10.CrossRefGoogle ScholarPubMed
Fondevila, C, Hessheimer, AJ, Taura, P, Sanchez, O, Calatayud, D, de Riva, N, et al. Portal Hyperperfusion: Mechanism of Injury and Stimulus for Regeneration in Porcine Small-for-Size Transplantation. Liver Transplantation: Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society. 2010;16(3):364–74.CrossRefGoogle ScholarPubMed
Kelly, DM, Demetris, AJ, Fung, JJ, Marcos, A, Zhu, Y, Subbotin, V, et al. Porcine Partial Liver Transplantation: A Novel Model of the “Small-for-Size” Liver Graft. Liver Transpl. 2004;10(2):253–63.CrossRefGoogle ScholarPubMed
Yagi, Y, Gilbertson, JR. Digital Imaging in Pathology: The Case for Standardization. Journal of Telemedicine and Telecare. 2005;11(3):109–16.CrossRefGoogle ScholarPubMed
Fukuhara, T, Umeda, K, Toshima, T, Takeishi, K, Morita, K, Nagata, S, et al. Congestion of the Donor Remnant Right Liver after Extended Left Lobe Donation. Transplant International: Official Journal of the European Society for Organ Transplantation. 2009;22(8):837–44.CrossRefGoogle ScholarPubMed
Man, K, Lo, CM, Ng, IO, Wong, YC, Qin, LF, Fan, ST, et al. Liver Transplantation in Rats Using Small-for-Size Grafts: A Study of Hemodynamic and Morphological Changes. Arch Surg. 2001;136(3):280–5.CrossRefGoogle ScholarPubMed
Asakura, T, Ohkohchi, N, Orii, T, Koyamada, N, Tsukamoto, S, Sato, M, et al. Portal Vein Pressure Is the Key for Successful Liver Transplantation of an Extremely Small Graft in the Pig Model. Transpl Int. 2003;16(6):376–82.CrossRefGoogle ScholarPubMed
Ayata, G, Pomfret, E, Pomposelli, JJ, Gordon, FD, Lewis, WD, Jenkins, RL, et al. Adult-to-Adult Live Donor Liver Transplantation: A Short-term Clinicopathologic Study. Hum Pathol. 2001;32(8):814–22.CrossRefGoogle ScholarPubMed
Pantanowitz, L, Pomfret, EA, Pomposelli, JJ, Lewis, WD, Gordon, FD, Jenkins, RL, et al. Pathologic Analysis of Right-lobe Graft Failure in Adult-to-Adult Live Donor Liver Transplantation. Int J Surg Pathol. 2003;11(4):283–94.CrossRefGoogle ScholarPubMed
Bekker, J, Ploem, S, de Jong, KP. Early Hepatic Artery Thrombosis after Liver Transplantation: A Systematic Review of the Incidence, Outcome and Risk Factors. American Journal of Transplantation: Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 2009;9(4):746–57.CrossRefGoogle ScholarPubMed
Gunsar, F, Rolando, N, Pastacaldi, S, Patch, D, Raimondo, ML, Davidson, B, et al. Late Hepatic Artery Thrombosis after Orthotopic Liver Transplantation. Liver Transplantation: Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society. 2003;9(6):605–11.CrossRefGoogle ScholarPubMed
Backman, L, Gibbs, J, Levy, M, McMillan, R, Holman, M, Husberg, B, et al. Causes of Late Graft Loss after Liver Transplantation. Transplantation. 1993;55(5):1078–82.CrossRefGoogle ScholarPubMed
Demetris, AJ, Qian, SG, Sun, H, Fung, JJ. Liver Allograft Rejection: An Overview of Morphologic Findings. The American Journal of Surgical Pathology. 1990;14(Suppl 1):4963.Google ScholarPubMed
Demetris, A, Kakizoe, S, S. O. Pathology of Liver Transplantation. In: Williams, JW, editor. Hepatic Transplantation. Philadelphia: WB Saunders; 1990. p. 61111.Google Scholar
Liu, TC, Nguyen, TT, Torbenson, MS. Concurrent Increase in Mitosis and Apoptosis: A Histological Pattern of Hepatic Arterial Flow Abnormalities in Post-transplant Liver Biopsies. Mod Pathol. 2012;25(12):1594–8.CrossRefGoogle ScholarPubMed
Ponziani, FR, Zocco, MA, Campanale, C, Rinninella, E, Tortora, A, Di Maurizio, L, et al. Portal Vein Thrombosis: Insight into Physiopathology, Diagnosis, and Treatment. World Journal of Gastroenterology: WJG. 2010;16(2):143–55.CrossRefGoogle ScholarPubMed
Alvarez, F. Portal Vein Complications after Pediatric Liver Transplantation. Curr Gastroenterol Rep. 2012;14(3):270–4.CrossRefGoogle ScholarPubMed
Kuang, AA, Renz, JF, Ferrell, LD, Ring, EJ, Rosenthal, P, Lim, RC, et al. Failure Patterns of Cryopreserved Vein Grafts in Liver Transplantation. Transplantation. 1996;62(6):742–7.CrossRefGoogle ScholarPubMed
Zahmatkeshan, M, Geramizadeh, B, Eshraghian, A, Nikeghbalian, S, Bahador, A, Salahi, H, et al. De Novo Fatty Liver due to Vascular Complications after Liver Transplantation. Transplantation Proceedings. 2011;43(2):615–7.CrossRefGoogle ScholarPubMed
Zhang, S, Dong, Z, Zhang, M, Xia, Q, Liu, D, Zhang, JJ. Right Lobe Living-donor Liver Transplantation with or without Middle Hepatic Vein: A Meta-analysis. Transplantation Proceedings. 2011;43(10):3773–9.CrossRefGoogle ScholarPubMed
Klintmalm, G, Busuttil, R. Transplantation of the Liver. Second ed. Klintmalm, G, Busuttil, R, editors. Philadelphia: Elsevier Saunders; 2005. 1485 p.Google Scholar
Sebagh, M, Debette, M, Samuel, D, Emile, JF, Falissard, B, Cailliez, V, et al. “Silent” Presentation of Veno-occlusive Disease after Liver Transplantation as Part of the Process of Cellular Rejection with Endothelial Predilection. Hepatology. 1999;30(5):1144–50.CrossRefGoogle ScholarPubMed
Pascher, A, Neuhaus, P. Bile Duct Complications after Liver Transplantation. Transpl Int. 2005;18(6):627–42.CrossRefGoogle ScholarPubMed
Ghobrial, RM, Busuttil, RW. Challenges of Adult Living-donor Liver Transplantation. J Hepatobiliary Pancreat Surg. 2006;13(2):139–45.CrossRefGoogle ScholarPubMed
Akamatsu, N, Sugawara, Y, Hashimoto, D. Biliary Reconstruction, Its Complications and Management of Biliary Complications after Adult Liver Transplantation: A Systematic Review of the Incidence, Risk Factors and Outcome. Transplant International: Official Journal of the European Society for Organ Transplantation. 2011;24(4):379–92.CrossRefGoogle ScholarPubMed
Kochhar, G, Parungao, JM, Hanouneh, IA, Parsi, MA. Biliary Complications Following Liver Transplantation. World J Gastroenterol. 2013;19(19):2841–6.CrossRefGoogle ScholarPubMed
Demetris, AJ, Murase, N, Nakamura, K, Iwaki, Y, Yagihashi, A, Valdivia, L, et al. Immunopathology of Antibodies as Effectors of Orthotopic Liver Allograft Rejection. Seminars in Liver Disease. 1992;12(1):51–9.CrossRefGoogle ScholarPubMed
Demetris, AJ, Jaffe, R, Tzakis, A, Ramsey, G, Todo, S, Belle, S, et al. Antibody-mediated Rejection of Human Orthotopic Liver Allografts. A Study of Liver Transplantation across ABO Blood Group Barriers. American Journal of Pathology. 1988;132(3):489502.Google ScholarPubMed
Demetris, AJ, Lunz, JG 3rd, Specht, S, Nozaki, I. Biliary Wound Healing, Ductular Reactions, and IL-6/gp130 Signaling in the Development of Liver Disease. World J Gastroenterol. 2006;12(22):3512–22.CrossRefGoogle ScholarPubMed
Verdonk, RC, Buis, CI, Porte, RJ, van der Jagt, EJ, Limburg, AJ, van den Berg, AP, et al. Anastomotic Biliary Strictures after Liver Transplantation: Causes and Consequences. Liver Transpl. 2006;12(5):726–35.CrossRefGoogle ScholarPubMed
Verdonk, RC, Buis, CI, Porte, RJ, Haagsma, EB. Biliary Complications after Liver Transplantation: A Review. Scand J Gastroenterol Suppl. 2006(243):89101.CrossRefGoogle Scholar
Verdonk, RC, Buis, CI, van der Jagt, EJ, Gouw, AS, Limburg, AJ, Slooff, MJ, et al. Nonanastomotic Biliary Strictures after Liver Transplantation, Part 2: Management, Outcome, and Risk Factors for Disease Progression. Liver Transpl. 2007;13(5):725–32.CrossRefGoogle ScholarPubMed
Buis, CI, Verdonk, RC, Van der Jagt, EJ, van der Hilst, CS, Slooff, MJ, Haagsma, EB, et al. Nonanastomotic Biliary Strictures after Liver Transplantation, Part 1: Radiological Features and Risk Factors for Early vs. Late Presentation. Liver Transpl. 2007;13(5):708–18.CrossRefGoogle ScholarPubMed
Song, GW, Lee, SG, Hwang, S, Kim, KH, Ahn, CS, Moon, DB, et al. Biliary Stricture is the Only Concern in ABO-incompatible Adult Living Donor Liver Transplantation in the Rituximab Era. Journal of Hepatology. 2014;61(3):575–82.CrossRefGoogle ScholarPubMed
Foley, DP, Fernandez, LA, Leverson, G, Chin, LT, Krieger, N, Cooper, JT, et al. Donation after Cardiac Death: The University of Wisconsin Experience with Liver Transplantation. Ann Surg. 2005;242(5):724–31.CrossRefGoogle ScholarPubMed
Demetris, A, Crawford, J, Nalesnik, M, Randhawa, P, Wu, T, Minervini, M. Transplantation Pathology of the Liver. In: Odze, R, Goldblum, J, Crawford, JM, editors. Surgical Pathology of the GI Tract, Liver, Biliary Tract, and Pancreas. Philadelphia: WB Saunders; 2004. p. 909–66.Google Scholar
Pirenne, J, Aerts, R, Yoong, K, Gunson, B, Koshiba, T, Fourneau, I, et al. Liver Transplantation for Polycystic Liver Disease. Liver Transpl. 2001;7(3):238–45.CrossRefGoogle ScholarPubMed
Minor, T, Hachenberg, A, Tolba, R, Pauleit, D, Akbar, S. Fibrinolytic Preflush upon Liver Retrieval from Non-Heart Beating Donors to Enhance Postpreservation Viability and Energetic Recovery upon Reperfusion. Transplantation. 2001;71(12):1792–6.CrossRefGoogle ScholarPubMed
Demetris, AJ, Fontes, P, Lunz, JG 3rd, Specht, S, Murase, N, Marcos, A. Wound Healing in the Biliary Tree of Liver Allografts. Cell Transplant. 2006;15 Suppl 1:S5765.CrossRefGoogle ScholarPubMed
Demetris, AJ, Nakamura, K, Yagihashi, A, Iwaki, Y, Takaya, S, Hartman, GG, et al. A Clinicopathological Study of Human Liver Allograft Recipients Harboring Preformed IgG Lymphocytotoxic Antibodies. Hepatology. 1992;16(3):671–81.CrossRefGoogle ScholarPubMed
Sanchez-Urdazpal, L, Batts, KP, Gores, GJ, Moore, SB, Sterioff, S, Wiesner, RH, et al. Increased Bile Duct Complications in Liver Transplantation across the ABO Barrier. Ann Surg. 1993;218(2):152–8.CrossRefGoogle ScholarPubMed
Jorgensen, JE, Waljee, AK, Volk, ML, Sonnenday, CJ, Elta, GH, Al-Hawary, MM, et al. Is MRCP Equivalent to ERCP for Diagnosing Biliary Obstruction in Orthotopic Liver Transplant Recipients? A Meta-analysis. Gastrointest Endosc. 2011;73(5):955–62.CrossRefGoogle ScholarPubMed
Boraschi, P, Donati, F. Postoperative Biliary Adverse Events Following Orthotopic Liver Transplantation: Assessment with Magnetic Resonance Cholangiography. World J Gastroenterol. 2014;20(32):11080–94.CrossRefGoogle ScholarPubMed
Girometti, R, Como, G, Bazzocchi, M, Zuiani, C. Post-operative Imaging in Liver Transplantation: State-of-the-Art and Future Perspectives. World J Gastroenterol. 2014;20(20):6180–200.CrossRefGoogle ScholarPubMed
Hartshorne, N, Hartman, G, Markin, RS, Demetris, AJ, Ferrell, L. Bile Duct Hemorrhage: A Biopsy Finding after Cholangiography or Biliary Tree Manipulation. Liver. 1992;12(3):137–9.Google ScholarPubMed
Nagral, A, Ben-Ari, Z, Dhillon, AP, Burroughs, AK. Eosinophils in Acute Cellular Rejection in Liver Allografts. Liver Transpl Surg. 1998;4(5):355–62.CrossRefGoogle ScholarPubMed
O’Leary, JG, Michelle Shiller, S, Bellamy, C, Nalesnik, MA, Kaneku, H, Jennings, LW, et al. Acute Liver Allograft Antibody-mediated Rejection: An Inter-institutional Study of Significant Histopathological Features. Liver Transpl. 2014;20(10):1244–55.Google ScholarPubMed
Lunz, JG 3rd, Contrucci, S, Ruppert, K, Murase, N, Fung, JJ, Starzl, TE, et al. Replicative Senescence of Biliary Epithelial Cells Precedes Bile Duct Loss in Chronic Liver Allograft Rejection: Increased Expression of p21(WAF1/Cip1) as a Disease Marker and the Influence of Immunosuppressive Drugs. Am J Pathol. 2001;158(4):1379–90.CrossRefGoogle ScholarPubMed
Demetris, AJ. Distinguishing between Recurrent Primary Sclerosing Cholangitis and Chronic Rejection. Liver Transpl. 2006;12(11 Suppl 2):S6872.CrossRefGoogle ScholarPubMed
Demetris, AJ, Crawford, JM, Isse, K, Minervini, MI, Nalesnik, MA, Rubin, E, et al. Pathology of Liver and Hematopoietic Stem Cell Transplantation. In: Odze, RD, Goldblum, JR, editors. Surgical Pathology of the GI Tract, Liver, Biliary Tract and Pancreas 3rd ed. Philadelphia, PA: Elsevier/Saunders; 2015. p. 1408–61.Google Scholar
Clendenon, JN, Aranda-Michel, J, Krishna, M, Taner, CB, Willingham, DL. Recurrent Liver Failure Caused by IgG4 Associated Cholangitis. Ann Hepatol. 2011;10(4):562–4.Google ScholarPubMed
Demetris, AJ, Eghtesad, B, Marcos, A, Ruppert, K, Nalesnik, MA, Randhawa, P, et al. Recurrent Hepatitis C in Liver Allografts: Prospective Assessment of Diagnostic Accuracy, Identification of Pitfalls, and Observations about Pathogenesis. Am J Surg Pathol. 2004;28(5):658–69.CrossRefGoogle ScholarPubMed
O’Leary, JG, Kaneku, H, Demetris, AJ, Marr, JD, Shiller, SM, Susskind, BM, et al. Antibody-mediated Rejection as a Contributor to Previously Unexplained Early Liver Allograft Loss. Liver Transpl. 2014;20(2):218–27.Google ScholarPubMed
Kozlowski, T, Andreoni, K, Schmitz, J, Hayashi, PH, Nickeleit, V. Sinusoidal C4d Deposits in Liver Allografts Indicate an Antibody-mediated Response: Diagnostic Considerations in the Evaluation of Liver Allografts. Liver Transpl. 2012;18(6):641–58.CrossRefGoogle ScholarPubMed
Gelson, W, Hoare, M, Dawwas, MF, Vowler, S, Gibbs, P, Alexander, G. The Pattern of Late Mortality in Liver Transplant Recipients in the United Kingdom. Transplantation. 2011;91(11):1240–4.CrossRefGoogle ScholarPubMed
Duffy, JP, Kao, K, Ko, CY, Farmer, DG, McDiarmid, SV, Hong, JC, et al. Long-term Patient Outcome and Quality of Life after Liver Transplantation: Analysis of 20-year Survivors. Ann Surg. 2010;252(4):652–61.Google ScholarPubMed
O’Leary, JG, Demetris, AJ, Friedman, LS, Gebel, HM, Halloran, PF, Kirk, AD, et al. The Role of Donor-specific HLA Alloantibodies in Liver Transplantation. Am J Transplant. 2014;14(4):779–87.Google ScholarPubMed
Salah, A, Fujimoto, M, Yoshizawa, A, Yurugi, K, Miyagawa-Hayashino, A, Sumiyoshi, S, et al. Application of Complement Component 4d Immunohistochemistry to ABO-compatible and ABO-incompatible Liver Transplantation. Liver Transpl. 2014;20(2):200–9.CrossRefGoogle ScholarPubMed
Rose, ML, West, LJ. Accommodation: Does It Apply to Human Leukocyte Antigens? Transplantation. 2012;93(3):244–6.CrossRefGoogle ScholarPubMed
Raut, V, Uemoto, S. Management of ABO-incompatible Living-donor Liver Transplantation: Past and Present Trends. Surg Today. 2011;41(3):317–22.CrossRefGoogle ScholarPubMed
Haga, H, Egawa, H, Shirase, T, Miyagawa, A, Sakurai, T, Minamiguchi, S, et al. Periportal Edema and Necrosis as Diagnostic Histological Features of Early Humoral Rejection in ABO-incompatible Liver Transplantation. Liver Transpl. 2004;10(1):1627.CrossRefGoogle ScholarPubMed
Ruiz, R, Tomiyama, K, Campsen, J, Goldstein, RM, Levy, MF, McKenna, GJ, et al. Implications of a Positive Crossmatch in Liver Transplantation: A 20-year Review. Liver Transplantation: Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society. 2011.
Al-Sibae, MR, Koffron, AJ, Raofi, V. Does a Positive Pretransplant Crossmatch Affect Long-term Outcome in Liver Transplantation? Transplantation. 2011;91(3):261–2.CrossRefGoogle ScholarPubMed
Chan, KM, Lee, CS, Wu, TJ, Lee, CF, Chen, TC, Lee, WC. Clinical Perspective of Acute Humoral Rejection after Blood Type-compatible Liver Transplantation. Transplantation. 2011;91(5):e2930.CrossRefGoogle ScholarPubMed
O’Leary, J, Kaneku, H, Banuelos, N, Jennings, L, Klintmalm, G, Terasaki, P. Impact of IgG3 Subclass and C1q-fixing Donor Specific Antibodies on Rejection and Survival in Liver Transplantation. American Journal of Transplantation. 2015;(in press).
O’Leary, JG, Kaneku, H, Jennings, L, Susskind, BM, Terasaki, PI, Klintmalm, GB. Donor-specific Slloantibodies Are Associated with Fibrosis Progression after Liver Transplantation in Hepatitis C Virus-infected Patients. Liver Transpl. 2014;20(6):655–63.Google ScholarPubMed
Castillo-Rama, M, Castro, MJ, Bernardo, I, Meneu-Diaz, JC, Elola-Olaso, AM, Calleja-Antolin, SM, et al. Preformed Antibodies Detected by Cytotoxic Assay or Multibead Array Decrease Liver Allograft Survival: Role of Human Leukocyte Antigen Compatibility. Liver Transpl. 2008;14(4):554–62.CrossRefGoogle ScholarPubMed
O’Leary, JG, Klintmalm, GB. Impact of Donor-specific Antibodies on Results of Liver Transplantation. Curr Opin Organ Transplant. 2013;18(3):279–84.CrossRefGoogle ScholarPubMed
Taner, T, Gandhi, MJ, Sanderson, SO, Poterucha, CR, De Goey, SR, Stegall, MD, et al. Prevalence, Course and Impact of HLA Donor-specific Antibodies in Liver Transplantation in the First Year. Am J Transplant. 2012;12(6):1504–10.CrossRefGoogle ScholarPubMed
Manez, R, Kelly, RH, Kobayashi, M, Takaya, S, Bronsther, O, Kramer, D, et al. Immunoglobulin G Lymphocytotoxic Antibodies in Clinical Liver Transplantation: Studies Toward Further Defining Their Significance. Hepatology. 1995;21(5):1345–52.CrossRefGoogle ScholarPubMed
Doyle, HR, Marino, IR, Morelli, F, Doria, C, Aldrighetti, L, McMichael, J, et al. Assessing Risk in Liver Transplantation. Special Reference to the Significance of a Positive Cytotoxic Crossmatch. Ann Surg. 1996;224(2):168–77.CrossRefGoogle Scholar
Kozlowski, T, Rubinas, T, Nickeleit, V, Woosley, J, Schmitz, J, Collins, D, et al. Liver Allograft Antibody-mediated Rejection with Demonstration of Sinusoidal C4d Staining and Circulating Donor-specific Antibodies. Liver Transplantation: Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society. 2011;17(4):357–68.CrossRefGoogle ScholarPubMed
Hubscher, SG. Antibody-mediated Rejection in the Liver Allograft. Curr Opin Organ Transplant. 2012;17(3):280–6.Google ScholarPubMed
Demetris, AJ, Bellamy, C, Hubscher, SG, O’Leary, J, Randhawa, PS, Feng, S, et al. 2016 Comprehensive Update of the BANFF Working Group on Liver Allograft Pathology: Introduction of Antibody-mediated Rejection. Am J Transplant. 2016.
Haga, H, Egawa, H, Fujimoto, Y, Ueda, M, Miyagawa-Hayashino, A, Sakurai, T, et al. Acute Humoral Rejection and C4d Immunostaining in ABO Blood Type-incompatible Liver Transplantation. Liver Transpl. 2006;12(3):457–64.CrossRefGoogle ScholarPubMed
Egawa, H, Uemoto, S, Inomata, Y, Shapiro, AM, Asonuma, K, Kiuchi, T, et al. Biliary Complications in Pediatric Living Related Liver Transplantation. Surgery. 1998;124(5):901–10.CrossRefGoogle ScholarPubMed
Sebagh, M, Farges, O, Kalil, A, Samuel, D, Bismuth, H, Reynes, M. Sclerosing Cholangitis Following Human Orthotopic Liver Transplantation. The American Journal of Surgical Pathology. 1995;19(1):8190.CrossRefGoogle ScholarPubMed
Iacob, S, Cicinnati, VR, Dechêne, A, Lindemann, M, Heinemann, FM, Rebmann, V, et al. Genetic, Immunological and Clinical Risk Factors for Biliary Strictures Following Liver Transplantation. Liver International: Official Journal of the International Association for the Study of the Liver. 2012;32(8):1253–61.CrossRefGoogle ScholarPubMed
Manez, R, Kobayashi, M, Takaya, S, Bronsther, O, Kramer, D, Bonet, H, et al. Humoral Rejection Associated with Antidonor Lymphocytotoxic Antibodies Following Liver Transplantation. Transplantation Proceedings. 1993;25(1 Pt 2):888–90.Google ScholarPubMed
Musat, AI, Agni, RM, Wai, PY, Pirsch, JD, Lorentzen, DF, Powell, A, et al. The Significance of Donor-specific HLA Antibodies in Rejection and Ductopenia Development in ABO Compatible Liver Transplantation. American Journal of Transplantation: Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 2011;11(3):500–10.CrossRefGoogle ScholarPubMed
Bellamy, CO. Complement C4d Immunohistochemistry in the Assessment of Liver Allograft Biopsy Samples: Applications and Pitfalls. Liver Transplantation: Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society. 2011;17(7):747–50.CrossRefGoogle ScholarPubMed
Grabhorn, E, Binder, TM, Obrecht, D, Brinkert, F, Lehnhardt, A, Herden, U, et al. Long-term Clinical Relevance of De Novo Donor-specific Antibodies after Pediatric Liver Transplantation. Transplantation. 2015.
Markiewicz-Kijewska, M, Kaliciński, P, Kluge, P, Piątosa, B, Jankowska, I, Rękawek, A, et al. Immunological Factors and Liver Fibrosis in Pediatric Liver Transplant Recipients. Ann Transplant. 2015;20:279–84.Google ScholarPubMed
Wozniak, LJ, Hickey, MJ, Venick, RS, Vargas, JH, Farmer, DG, Busuttil, RW, et al. Donor-specific HLA Antibodies Are Associated with Late Allograft Dysfunction after Pediatric Liver Transplantation. Transplantation. 2015.
Ohe, H, Uchida, Y, Yoshizawa, A, Hirao, H, Taniguchi, M, Maruya, E, et al. Association of Anti-human Leukocyte Antigen and Anti-angiotensin II Type 1 Receptor Antibodies with Liver Allograft Fibrosis after Immunosuppression Withdrawal. Transplantation. 2014;98(10):1105–11.CrossRefGoogle ScholarPubMed
Kosola, S, Lampela, H, Jalanko, H, Makisalo, H, Lohi, J, Arola, J, et al. Low-dose Steroids Associated with Milder Histological Changes after Pediatric Liver Transplantation. Liver Transpl. 2013;19(2):145–54.CrossRefGoogle ScholarPubMed
Miyagawa-Hayashino, A, Yoshizawa, A, Uchida, Y, Egawa, H, Yurugi, K, Masuda, S, et al. Progressive Graft Fibrosis and Donor-specific Human Leukocyte Antigen Antibodies in Pediatric Late Liver Allografts. Liver Transpl. 2012;18(11):1333–42.CrossRefGoogle ScholarPubMed
Yamada, H, Kondou, H, Kimura, T, Ikeda, K, Tachibana, M, Hasegawa, Y, et al. Humoral Immunity Is Involved in the Development of Pericentral Fibrosis after Pediatric Live Donor Liver Transplantation. Pediatr Transplant. 2012;16(8):858–65.CrossRefGoogle ScholarPubMed
Girnita, A, Mazariegos, GV, Castellaneta, A, Reyes, J, Bentlejewski, C, Thomson, AW, et al. Liver Transplant Recipients Weaned off Immunosuppression Lack Circulating Donor-specific Antibodies. Hum Immunol. 2010;71(3):274–6.CrossRefGoogle ScholarPubMed
Kaneku, H, O’Leary, JG, Banuelos, N, Jennings, LW, Susskind, BM, Klintmalm, GB, et al. De Novo Donor-specific HLA Antibodies Decrease Patient and Graft Survival in Liver Transplant Recipients. Am J Transplant. 2013;13(6):1541–8.CrossRefGoogle ScholarPubMed
O’Leary, JG, Cai, J, Freeman, R, Banuelos, N, Hart, B, Johnson, M, et al. Proposed Diagnostic Criteria for Chronic Antibody-mediated Rejection in Liver Allografts. Am J Transplant. 2015.
Yoshitomi, M, Koshiba, T, Haga, H, Li, Y, Zhao, X, Cheng, D, et al. Requirement of Protocol Biopsy before and after Complete Cessation of Immunosuppression after Liver Transplantation. Transplantation. 2009;87(4):606–14.CrossRefGoogle ScholarPubMed
Egawa, H, Miyagawa-Hayashino, A, Haga, H, Teramukai, S, Yoshizawa, A, Ogawa, K, et al. Non-inflammatory Centrilobular Sinusoidal Fibrosis in Pediatric Liver Transplant Recipients under Tacrolimus Withdrawal. Hepatology Research: The Official Journal of the Japan Society of Hepatology. 2012;42(9):895903.CrossRefGoogle ScholarPubMed
Demetris, AJ, Adeyi, O, Bellamy, CO, Clouston, A, Charlotte, F, Czaja, A, et al. Liver Biopsy Interpretation for Causes of Late Liver Allograft Dysfunction. Hepatology. 2006;44(2):489501.Google ScholarPubMed
Demetris, AJ, Lunz, JG 3rd, Randhawa, P, Wu, T, Nalesnik, M, Thomson, AW. Monitoring of Human Liver and Kidney Allograft Tolerance: A Tissue/Histopathology Perspective. Transpl Int. 2009;22(1):120–41.CrossRefGoogle Scholar
Benitez, C, Londono, MC, Miquel, R, Manzia, TM, Abraldes, JG, Lozano, JJ, et al. Prospective Multicenter Clinical Trial of Immunosuppressive Drug Withdrawal in Stable Adult Liver Transplant Recipients. Hepatology. 2013.
Feng, S, Demetris, AJ, Ekong, U, Girnita, A, Kanaparthi, S, Soppe, C, et al., editors. Serum and Tissue DSA Subclass, Stellate and Endothelial Phenotype Monitoring in ITN029ST Tolerance Pediatric Liver Transplant Recipients over 5+ Years of Follow-up. Joint International Conference of ILTS, ELITA & LICAGE; 2014; London.Google Scholar
Hubscher, SG. What Is the Long-term Outcome of the Liver Allograft? Journal of Hepatology. 2011;55(3):702–17.CrossRefGoogle ScholarPubMed
Smith, RN, Colvin, RB. Chronic Alloantibody Mediated Rejection. Semin Immunol. 2012;24(2):115–21.CrossRefGoogle ScholarPubMed
Bellamy, CO, Herriot, MM, Harrison, DJ, Bathgate, AJ. C4d Immunopositivity Is Uncommon in ABO-compatible Liver Allografts, but Correlates Partially with Lymphocytotoxic Antibody Status. Histopathology. 2007;50(6):739–49.CrossRefGoogle ScholarPubMed
Iacob, S, Cicinnati, VR, Lindemann, M, Heinemann, FM, Radtke, A, Kaiser, GM, et al. Donor-Specific Anti-HLA Antibodies and Endothelial C4d Deposition-Association with Chronic Liver Allograft Failure. Transplantation. 2015;99(9):1869–75.CrossRefGoogle ScholarPubMed
Seemayer, CA, Gaspert, A, Nickeleit, V, Mihatsch, MJ. C4d Staining of Renal Allograft Biopsies: A Comparative Analysis of Different Staining Techniques. Nephrol Dial Transplant. 2007;22(2):568–76.Google ScholarPubMed
Nadasdy, GM, Bott, C, Cowden, D, Pelletier, R, Ferguson, R, Nadasdy, T. Comparative Study for the Detection of Peritubular Capillary C4d Deposition in Human Renal Allografts Using Different Methodologies. Hum Pathol. 2005;36(11):1178–85.CrossRefGoogle ScholarPubMed
Bu, X, Zheng, Z, Yu, Y, Zeng, L, Jiang, Y. Significance of C4d Deposition in the Diagnosis of Rejection after Liver Transplantation. Transplant Proc. 2006;38(5):1418–21.CrossRefGoogle Scholar
Dankof, A, Schmeding, M, Morawietz, L, Gunther, R, Krukemeyer, MG, Rudolph, B, et al. Portal Capillary C4d Deposits and Increased Infiltration by Macrophages Indicate Humorally Mediated Mechanisms in Acute Cellular Liver Allograft Rejection. Virchows Arch. 2005;447(1):8793.CrossRefGoogle ScholarPubMed
Jain, A, Mohanka, R, Orloff, M, Abt, P, Romano, J, Bryan, L, et al. Characterization of CD4, CD8, CD56 Positive Lymphocytes and C4d Deposits to Distinguish Acute Cellular Rejection from Recurrent Hepatitis C in Post-liver Transplant Biopsies. Clin Transplant. 2006;20(5):624–33.CrossRefGoogle ScholarPubMed
Krukemeyer, MG, Moeller, J, Morawietz, L, Rudolph, B, Neumann, U, Theruvath, T, et al. Description of B Lymphocytes and Plasma Cells, Complement, and Chemokines/Receptors in Acute Liver Allograft Rejection. Transplantation. 2004;78(1):6570.CrossRefGoogle ScholarPubMed
Sakashita, H, Haga, H, Ashihara, E, Wen, MC, Tsuji, H, Miyagawa-Hayashino, A, et al. Significance of C4d Staining in ABO-identical/Compatible Liver Transplantation. Mod Pathol. 2007;20(6):676–84.CrossRefGoogle ScholarPubMed
Sawada, T, Shimizu, A, Kubota, K, Fuchinoue, S, Teraoka, S. Lobular Damage Caused by Cellular and Humoral Immunity in Liver Allograft Rejection. Clin Transplant. 2005;19(1):110–4.CrossRefGoogle ScholarPubMed
Troxell, ML, Higgins, JP, Kambham, N. Evaluation of C4d Staining in Liver and Small Intestine Allografts. Arch Pathol Lab Med. 2006;130(10):1489–96.Google ScholarPubMed
Bouron-Dal Soglio, D, Rougemont, AL, Herzog, D, Soucy, G, Alvarez, F, Fournet, JC. An Immunohistochemical Evaluation of C4d Deposition in Pediatric Inflammatory Liver Diseases. Human Pathology. 2008;39(7):1103–10.CrossRefGoogle ScholarPubMed
Aguilera, I, Sousa, JM, Gavilan, F, Gomez, L, Alvarez-Marquez, A, Nunez-Roldan, A. Complement Component 4d Immunostaining in Liver Allografts of Patients with de Novo Immune Hepatitis. Liver Transplantation: Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society. 2011;17(7):779–88.CrossRefGoogle ScholarPubMed
Schmeding, M, Dankof, A, Krenn, V, Krukemeyer, MG, Koch, M, Spinelli, A, et al. C4d in Acute Rejection after Liver Transplantation–A Valuable Tool in Differential Diagnosis to Hepatitis C Recurrence. Am J Transplant. 2006;6(3):523–30.CrossRefGoogle ScholarPubMed
Silva, MA, Mirza, DF, Murphy, N, Richards, DA, Reynolds, GM, Wigmore, SJ, et al. Intrahepatic Complement Activation, Sinusoidal Endothelial Injury, and Lactic Acidosis Are Associated with Initial Poor Function of the Liver after Transplantation. Transplantation. 2008;85(5):718–25.CrossRefGoogle ScholarPubMed
Martelius, T, Halme, L, Arola, J, Hockerstedt, K, Lautenschlager, I. Vascular Deposition of Complement C4d Is Increased in Liver Allografts with Chronic Rejection. Transpl Immunol. 2009;21(4):244–6.CrossRefGoogle ScholarPubMed
Anonymous. Terminology for Hepatic Allograft Rejection. International Working Party. Hepatology. 1995;22(2):648–54.
Knechtle, SJ, Kwun, J. Unique Aspects of Rejection and Tolerance in Liver Transplantation. Seminars in Liver Disease. 2009;29(1):91101.CrossRefGoogle ScholarPubMed
Neuberger, J. Incidence, Timing, and Risk Factors for Acute and Chronic Rejection. Liver Transpl Surg. 1999;5(4 Suppl 1):S306.Google ScholarPubMed
Demetris, AJ, Ruppert, K, Dvorchik, I, Jain, A, Minervini, M, Nalesnik, MA, et al. Real-time Monitoring of Acute Liver-allograft Rejection Using the BANFF Schema. Transplantation. 2002;74(9):1290–6.CrossRefGoogle ScholarPubMed
Germani, G, Rodriguez-Castro, K, Russo, FP, Senzolo, M, Zanetto, A, Ferrarese, A, et al. Markers of Acute Rejection and Graft Acceptance in Liver Transplantation. World J Gastroenterol. 2015;21(4):1061–8.CrossRefGoogle ScholarPubMed
Neil, DA, Hubscher, SG. Current Views on Rejection Pathology in Liver Transplantation. Transplant International: Official Journal of the European Society for Organ Transplantation. 2010;23(10):971–83.CrossRefGoogle ScholarPubMed
Uemura, T, Ikegami, T, Sanchez, EQ, Jennings, LW, Narasimhan, G, McKenna, GJ, et al. Late Acute Rejection after Liver Transplantation Impacts Patient Survival. Clin Transplant. 2008;22(3):316–23.CrossRefGoogle ScholarPubMed
Neil, DA, Hubscher, SG. Are Parenchymal Changes in Early Post-transplant Biopsies Related to Preservation-Reperfusion Injury or Rejection? Transplantation. 2001;71(11):1566–72.CrossRefGoogle ScholarPubMed
Anonymous. BANFF Schema for Grading Liver Allograft Rejection: An International Consensus Document. Hepatology. 1997;25(3):658–63.
Yeh, MM, Larson, AM, Tung, BY, Swanson, PE, Upton, MP. Endotheliitis in Chronic Viral Hepatitis: A Comparison with Acute Cellular Rejection and Non-alcoholic Steatohepatitis. The American Journal of Surgical Pathology. 2006;30(6):727–33.CrossRefGoogle ScholarPubMed
Demetris, AJ, Lasky, S, Van Thiel, DH, Starzl, TE, Dekker, A. Pathology of Hepatic Transplantation: A Review of 62 Adult Allograft Recipients Immunosuppressed with a Cyclosporine/Steroid Regimen. Am J Pathol. 1985;118(1):151–61.Google ScholarPubMed
McCaughan, GW, Davies, JS, Waugh, JA, Bishop, GA, Hall, BM, Gallagher, ND, et al. A Quantitative Analysis of T Lymphocyte Populations in Human Liver Allografts Undergoing Rejection: The Use of Monoclonal Antibodies and Double Immunolabeling. Hepatology. 1990;12(6):1305–13.CrossRefGoogle ScholarPubMed
Steinhoff, G, Behrend, M, Wonigeit, K. Expression of Adhesion Molecules on Lymphocytes/Monocytes and Hepatocytes in Human Liver Grafts. Hum Immunol. 1990;28(2):123–7.CrossRefGoogle ScholarPubMed
Demetris, AJ, Belle, SH, Hart, J, Lewin, K, Ludwig, J, Snover, DC, et al. Intraobserver and Interobserver Variation in the Histopathological Assessment of Liver Allograft Rejection. The Liver Transplantation Database (LTD) Investigators. Hepatology. 1991;14(5):751–5.Google ScholarPubMed
Cong, WM, Zhang, SY, Wang, ZL, Xue, L, Liu, YS, Zhang, SH. [Pathologic Diagnosis of 1123 Post-transplant Liver Biopsies from 665 Liver Transplant Patients]. Zhonghua Bing Li Xue Za Zhi. 2005;34(11):716–9.Google Scholar
Netto, GJ, Watkins, DL, Williams, JW, Colby, TV, dePetris, G, Sharkey, FE, et al. Interobserver Agreement in Hepatitis C Grading and Staging and in the BANFF Grading Schema for Acute Cellular Rejection: The “Hepatitis C 3” Multi-institutional Trial Experience. Arch Pathol Lab Med. 2006;130(8):1157–62.Google ScholarPubMed
Demirhan, B, Bilezikci, B, Haberal, AN, Sevmis, S, Arat, Z, Haberal, M. Hepatic Parenchymal Changes and Histologic Eosinophilia as Predictors of Subsequent Acute Liver Allograft Rejection. Liver Transpl. 2008;14(2):214–9.CrossRefGoogle ScholarPubMed
Hubscher, S. Diagnosis and Grading of Liver Allograft Rejection: A European Perspective. Transplant Proc. 1996;28(1):504–7.Google ScholarPubMed
Ishak, K, Baptista, A, Bianchi, L, Callea, F, De Groote, J, Gudat, F, et al. Histological Grading and Staging of Chronic Hepatitis. Journal of Hepatology. 1995;22(6):696–9.CrossRefGoogle ScholarPubMed
Tsamandas, AC, Jain, AB, Felekouras, ES, Fung, JJ, Demetris, AJ, Lee, RG. Central Venulitis in the Allograft Liver: A Clinicopathologic Study. Transplantation. 1997;64(2):252–7.CrossRefGoogle ScholarPubMed
Krasinskas, AM, Ruchelli, ED, Rand, EB, Chittams, JL, Furth, EE. Central Venulitis in Pediatric Liver Allografts. Hepatology. 2001;33(5):1141–7.CrossRefGoogle ScholarPubMed
Krasinskas, AM, Demetris, AJ, Poterucha, JJ, Abraham, SC. The Prevalence and Natural History of Untreated Isolated Central Perivenulitis in Adult Allograft Livers. Liver Transpl. 2008;14(5):625–32.CrossRefGoogle ScholarPubMed
Sanei, MH, Schiano, TD, Sempoux, C, Fan, C, Fiel, MI. Acute Cellular Rejection Resulting in Sinusoidal Obstruction Syndrome and Ascites Postliver Transplantation. Transplantation. 2011;92(10):1152–8.CrossRefGoogle ScholarPubMed
Demetris, AJ, Duquesnoy, RJ, Fung, JJ, Murase, N, Nalesnik, M, Randhawa, P, et al. Pathophysiology of Chronic Allograft Rejection [Internet]. Medscape Transplantation. 2000. Available from: www.transplantation.medscape.com/Medscape/transplantation/ClinicalMgmt/CM.v02/public/index.CM.v02.html.
Walter, T, Dumortier, J, Guillaud, O, Hervieu, V, Paliard, P, Scoazec, JY, et al. Rejection under Alpha Interferon Therapy in Liver Transplant Recipients. Am J Transplant. 2007;7(1):177–84.CrossRefGoogle ScholarPubMed
Stanca, CM, Fiel, MI, Kontorinis, N, Agarwal, K, Emre, S, Schiano, TD. Chronic Ductopenic Rejection in Patients with Recurrent Hepatitis C Virus Treated with Pegylated Interferon Alfa-2a and Ribavirin. Transplantation. 2007;84(2):180–6.CrossRefGoogle ScholarPubMed
Blakolmer, K, Gaulard, P, Mannhalter, C, Swerdlow, S, Fassati, LR, Rossi, G, et al. Unusual Peripheral T Cell Lymphoma Presenting as Acute Liver Failure and Reappearing in the Liver Allograft. Transplantation. 2000;70(12):1802–5.CrossRefGoogle ScholarPubMed
Blakolmer, K, Jain, A, Ruppert, K, Gray, E, Duquesnoy, R, Murase, N, et al. Chronic Liver Allograft Rejection in a Population Treated Primarily with Tacrolimus as Baseline Immunosuppression: Long-term Follow-up and Evaluation of Features for Histopathological Staging. Transplantation. 2000;69(11):2330–6.CrossRefGoogle Scholar
Demetris, AJ. Spectrum of Chronic Hepatic Allograft Rejection and Arteriopathy and the Controversy of Centrilobular Necrosis. Liver Transpl. 2000;6(1):102–3.Google ScholarPubMed
Evans, PC, Smith, S, Hirschfield, G, Rigopoulou, E, Wreghitt, TG, Wight, DG, et al. Recipient HLA-DR3, Tumour Necrosis Factor-alpha Promoter Allele-2 (Tumour Necrosis Factor-2) and Cytomegalovirus Infection are Interrelated Risk Factors for Chronic Rejection of Liver Grafts. Journal of Hepatology. 2001;34(5):711–5.CrossRefGoogle ScholarPubMed
O’Leary, JG, Kaneku, H, Susskind, BM, Jennings, LW, Neri, MA, Davis, GL, et al. High Mean Fluorescence Intensity Donor-specific Anti-HLA Antibodies Associated with Chronic Rejection Postliver Transplant. Am J Transplant. 2011;11(9):1868–76.CrossRefGoogle ScholarPubMed
Pappo, O, Ramos, H, Starzl, TE, Fung, JJ, Demetris, AJ. Structural Integrity and Identification of Causes of Liver Allograft Dysfunction Occurring More Than 5 Years after Transplantation. American Journal of Surgical Pathology. 1995;19(2):192206.CrossRefGoogle ScholarPubMed
Demetris, AJ, Murase, N, Starzl, TE, Fung, JJ. Pathology of Chronic Rejection: An Overview of Common Findings and Observations about Pathogenic Mechanisms and Possible Prevention. Graft. 1998;1:52–9.Google ScholarPubMed
Blakolmer, K, Seaberg, EC, Batts, K, Ferrell, L, Markin, R, Wiesner, R, et al. Analysis of the Reversibility of Chronic Liver Allograft Rejection Implications for a Staging Schema. Am J Surg Pathol. 1999;23(11):1328–39.CrossRefGoogle ScholarPubMed
Demetris, AJ, Fung, JJ, Todo, S, McCauley, J, Jain, A, Takaya, S, et al. Conversion of Liver Allograft Recipients from Cyclosporine to FK506 Immunosuppressive Therapy–A Clinicopathologic Study of 96 Patients. Transplantation. 1992;53(5):1056–62.CrossRefGoogle ScholarPubMed
White, RM, Zajko, AB, Demetris, AJ, Bron, KM, Dekker, A, Starzl, TE. Liver Transplant Rejection: Angiographic Findings in 35 Patients. AJR Am J Roentgenol. 1987;148(6):1095–8.CrossRefGoogle ScholarPubMed
Freese, DK, Snover, DC, Sharp, HL, Gross, CR, Savick, SK, Payne, WD. Chronic Rejection after Liver Transplantation: A Study of Clinical, Histopathological and Immunological Features. Hepatology. 1991;13(5):882–91.CrossRefGoogle ScholarPubMed
Hubscher, SG, Buckels, JA, Elias, E, McMaster, P, Neuberger, JM. Reversible Vanishing Bile Duct Syndrome after Liver Transplantation: Report of 6 Cases. Transplantation Proceedings. 1991;23(1 Pt 2):1415–6.Google ScholarPubMed
Hubscher, SG, Buckels, JA, Elias, E, McMaster, P, Neuberger, J. Vanishing Bile-duct Syndrome Following Liver Transplantation–Is It Reversible? Transplantation. 1991;51(5):1004–10.CrossRefGoogle ScholarPubMed
van den Heuvel, MC, de Jong, KP, Boot, M, Slooff, MJ, Poppema, S, Gouw, AS. Preservation of Bile Ductules Mitigates Bile Duct Loss. Am J Transplant. 2006;6(11):2660–71.CrossRefGoogle ScholarPubMed
Demetris, A, Adams, D, Bellamy, C, Blakolmer, K, Clouston, A, Dhillon, AP, et al. Update of the International BANFF Schema for Liver Allograft Rejection: Working Recommendations for the Histopathologic Staging and Reporting of Chronic Rejection. An International Panel. Hepatology. 2000;31(3):792–9.Google ScholarPubMed
O’Keeffe, C, Baird, AW, Nolan, N, McCormick, PA. Mast Cell Hyperplasia in Chronic Rejection after Liver Transplantation. Liver Transpl. 2002;8(1):50–7.Google ScholarPubMed
Sasaki, M, Ikeda, H, Haga, H, Manabe, T, Nakanuma, Y. Frequent Cellular Senescence in Small Bile Ducts in Primary Biliary Cirrhosis: A Possible Role in Bile Duct Loss. The Journal of Pathology. 2005;205(4):451–9.CrossRefGoogle ScholarPubMed
Rygiel, KA, Robertson, H, Willet, JD, Brain, JG, Burt, AD, Jones, DE, et al. T Cell-mediated Biliary Epithelial-to-Mesenchymal Transition in Liver Allograft Rejection. Liver Transplantation: Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society. 2010;16(5):567–76.Google Scholar
Crawford, AR, Lin, XZ, Crawford, JM. The Normal Adult Human Liver Biopsy: A Quantitative Reference Standard. Hepatology. 1998;28(2):323–31.CrossRefGoogle ScholarPubMed
Oguma, S, Belle, S, Starzl, TE, Demetris, AJ. A Histometric Analysis of Chronically Rejected Human Liver Allografts: Insights into the Mechanisms of Bile Duct Loss: Direct Immunologic and Ischemic Factors. Hepatology. 1989;9(2):204–9.CrossRefGoogle ScholarPubMed
Moreira, RK, Chopp, W, Washington, MK. The Concept of Hepatic Artery-bile Duct Parallelism in the Diagnosis of Ductopenia in Liver Biopsy Samples. The American Journal of Surgical Pathology. 2011;35(3):392403.CrossRefGoogle Scholar
Matsumoto, Y, McCaughan, GW, Painter, DM, Bishop, GA. Evidence that Portal Tract Microvascular Destruction Precedes Bile Duct Loss in Human Liver Allograft Rejection. Transplantation. 1993;56(1):6975.CrossRefGoogle ScholarPubMed
Neil, DA, Hubscher, SG. Histologic and Biochemical Changes during the Evolution of Chronic Rejection of Liver Allografts. Hepatology. 2002;35(3):639–51.CrossRefGoogle ScholarPubMed
Nakazawa, Y, Jonsson, JR, Walker, NI, Kerlin, P, Steadman, C, Lynch, SV, et al. Fibrous Obliterative Lesions of Veins Contribute to Progressive Fibrosis in Chronic Liver Allograft Rejection. Hepatology. 2000;32(6):1240–7.CrossRefGoogle ScholarPubMed
Rubin, RH, Tolkoff-Rubin, NE. Opportunistic Infections in Renal Allograft Recipients. Transplantation Proceedings. 1988;20(6 Suppl 8):12–8.Google ScholarPubMed
Kalil, AC, Opal, SM. Sepsis in the Severely Immunocompromised Patient. Current Infectious Disease Reports. 2015;17(6):487.CrossRefGoogle ScholarPubMed
Fishman, JA. Infections in Immunocompromised Hosts and Organ Transplant Recipients: Essentials. Liver Transpl. 2011;17 Suppl 3:S347.CrossRefGoogle ScholarPubMed
Helfrich, M, Ison, MG. Opportunistic Infections Complicating Solid Organ Transplantation with Alemtuzumab Induction. Transpl Infect Dis. 2015.
Pedersen, M, Seetharam, A. Infections after Orthotopic Liver Transplantation. J Clin Exp Hepatol. 2014;4(4):347–60.CrossRefGoogle ScholarPubMed
Bruminhent, J, Razonable, RR. Management of Cytomegalovirus Infection and Disease in Liver Transplant Recipients. World J Hepatol. 2014;6(6):370–83.CrossRefGoogle ScholarPubMed
Fehr, T, Cippa, PE, Mueller, NJ. Cytomegalovirus Post Kidney Transplantation: Prophylaxis versus Pre-emptive Therapy? Transpl Int. 2015.
Bai, X, Rogers, BB, Harkins, PC, Sommerauer, J, Squires, R, Rotondo, K, et al. Predictive Value of Quantitative PCR-based Viral Burden Analysis for Eight Human Herpesviruses in Pediatric Solid Organ Transplant Patients. J Mol Diagn. 2000;2(4):191201.CrossRefGoogle ScholarPubMed
Neoh, CF, Snell, G, Levvey, B, Morrissey, CO, Stewart, K, Kong, DC. Antifungal Prophylaxis in Lung Transplantation. International Journal of Antimicrobial Agents. 2014;44(3):194202.CrossRefGoogle ScholarPubMed
Razonable, RR, Emery, VC. Management of CMV Infection and Disease in Transplant Patients. 27–29 February 2004. Herpes: The Journal of the IHMF. 2004;11(3):7786.Google ScholarPubMed
Lautenschlager, I. CMV Infection, Diagnosis and Antiviral Strategies after Liver Transplantation. Transplant International: Official Journal of the European Society for Organ Transplantation. 2009;22(11):1031–40.CrossRefGoogle ScholarPubMed
Razonable, RR. Cytomegalovirus Infection after Liver Transplantation: Current Concepts and Challenges. World Journal of Gastroenterology: WJG. 2008;14(31):4849–60.CrossRefGoogle ScholarPubMed
Eid, AJ, Bakri, SJ, Kijpittayarit, S, Razonable, RR. Clinical Features and Outcomes of Cytomegalovirus Retinitis after Transplantation. Transpl Infect Dis. 2008;10(1):13–8.CrossRefGoogle ScholarPubMed
Demetris, AJ, Nalesnik, M, Randhawa, P, Wu, T, Minervini, M, Lai, C, et al. Histologic Patterns of Rejection and Other Causes of Liver Dysfunction. In: Busuttil, RW, Klintmalm, GB, editors. Transplantation of the Liver. Philadelphia: Elsevier Saunders; 2005. p. 1057–128.Google Scholar
Barkholt, LM, Ehrnst, A, Veress, B. Clinical Use of Immunohistopathologic Methods for the Diagnosis of Cytomegalovirus Hepatitis in Human Liver Allograft Biopsy Specimens. Scand J Gastroenterol. 1994;29(6):553–60.CrossRefGoogle Scholar
Mabruk, MJ. In Situ Hybridization: Detecting Viral Nucleic Acid in Formalin-fixed, Paraffin-embedded Tissue Samples. Expert Review of Molecular Diagnostics. 2004;4(5):653–61.CrossRefGoogle ScholarPubMed
O’Grady, JG, Alexander, GJ, Sutherland, S, Donaldson, PT, Harvey, F, Portmann, B, et al. Cytomegalovirus Infection and Donor/Recipient HLA Antigens: Interdependent Co-factors in Pathogenesis of Vanishing Bile-duct Syndrome after Liver Transplantation. Lancet. 1988;2(8606):302–5.Google ScholarPubMed
Lautenschlager, I, Hockerstedt, K, Jalanko, H, Loginov, R, Salmela, K, Taskinen, E, et al. Persistent Cytomegalovirus in Liver Allografts with Chronic Rejection. Hepatology. 1997;25(1):190–4.CrossRefGoogle ScholarPubMed
Paya, CV, Wiesner, RH, Hermans, PE, Larson-Keller, JJ, Ilstrup, DM, Krom, RA, et al. Lack of Association between Cytomegalovirus Infection, HLA Matching and the Vanishing Bile Duct Syndrome after Liver Transplantation. Hepatology. 1992;16(1):6670.CrossRefGoogle ScholarPubMed
Nourse, JP, Jones, K, Gandhi, MK. Epstein-Barr Virus-related Post-transplant Lymphoproliferative Disorders: Pathogenetic Insights for Targeted Therapy. American Journal of Transplantation: Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 2011;11(5):888–95.CrossRefGoogle ScholarPubMed
Cesarman, E. Gammaherpesvirus and Lymphoproliferative Disorders in Immunocompromised Patients. Cancer Lett. 2011;305(2):163–74.CrossRefGoogle ScholarPubMed
Nalesnik, MA. Clinicopathologic Characteristics of Post-transplant Lymphoproliferative Disorders. Recent Results Cancer Res. 2002;159:918.CrossRefGoogle ScholarPubMed
Allen, U, Preiksaitis, J. Epstein-barr Virus and Posttransplant Lymphoproliferative Disorder in Solid Organ Transplant Recipients. Am J Transplant. 2009;9 Suppl 4:S8796.CrossRefGoogle ScholarPubMed
Verghese, PS, Schmeling, DO, Knight, JA, Matas, AJ, Balfour, HH Jr. The Impact of Donor Viral Replication at Transplant on Recipient Infections Posttransplant: A Prospective Study. Transplantation. 2015;99(3):602–8.CrossRefGoogle ScholarPubMed
Jain, A, Nalesnik, M, Reyes, J, Pokharna, R, Mazariegos, G, Green, M, et al. Posttransplant Lymphoproliferative Disorders in Liver Transplantation: A 20-year experience. Ann Surg. 2002;236(4):429–36.CrossRefGoogle ScholarPubMed
Hartmann, C, Schuchmann, M, Zimmermann, T. Posttransplant Lymphoproliferative Disease in Liver Transplant Patients. Current Infectious Disease Reports. 2011;13(1):53–9.CrossRefGoogle ScholarPubMed
Narkewicz, MR, Green, M, Dunn, S, Millis, M, McDiarmid, S, Mazariegos, G, et al. Decreasing Incidence of Symptomatic Epstein-Barr Virus Disease and Posttransplant Lymphoproliferative Disorder in Pediatric Liver Transplant Recipients: Report of the Studies of Pediatric Liver Transplantation Experience. Liver Transpl. 2013;19(7):730–40.CrossRefGoogle ScholarPubMed
Koch, DG, Christiansen, L, Lazarchick, J, Stuart, R, Willner, IR, Reuben, A. Posttransplantation Lymphoproliferative Disorder–The Great Mimic in Liver Transplantation: Appraisal of the Clinicopathologic Spectrum and the Role of Epstein-Barr Virus. Liver Transpl. 2007;13(6):904–12.CrossRefGoogle ScholarPubMed
Niller, HH, Wolf, H, Minarovits, J. Regulation and Dysregulation of Epstein-Barr Virus Latency: Implications for the Development of Autoimmune Diseases. Autoimmunity. 2008;41(4):298328.CrossRefGoogle ScholarPubMed
Randhawa, PS, Markin, RS, Starzl, TE, Demetris, AJ. Epstein-Barr Virus-associated Syndromes in Immunosuppressed Liver Transplant Recipients. Clinical Profile and Recognition on Routine Allograft Biopsy. Am J Surg Pathol. 1990;14(6):538–47.CrossRefGoogle ScholarPubMed
Randhawa, PS, Jaffe, R, Demetris, AJ, Nalesnik, M, Starzl, TE, Chen, YY, et al. The Systemic Distribution of Epstein-Barr Virus Genomes in Fatal Post-Transplantation Lymphoproliferative Disorders. An in Situ Hybridization Study. Am J Pathol. 1991;138(4):1027–33.Google ScholarPubMed
Randhawa, PS, Jaffe, R, Demetris, AJ, Nalesnik, M, Starzl, TE, Chen, YY, et al. Expression of Epstein-Barr Virus-encoded Small RNA (by the EBER-1 Gene) in Liver Specimens from Transplant Recipients with Post-transplantation Lymphoproliferative Disease. N Engl J Med. 1992;327(24):1710–4.CrossRefGoogle ScholarPubMed
Jha, B, Gajendra, S, Sachdev, R, Goel, S, Sahni, T, Raina, V. Prompt Diagnosis and Management of Epstein-Barr Virus-associated Post-transplant Lymphoproliferative Disorder and Hemophagocytosis: A Dreaded Complication in a Post-liver Transplant Child. Pediatr Transplant. 2015.
Cockfield, SM. Identifying the Patient at Risk for Post-transplant Lymphoproliferative Disorder. Transpl Infect Dis. 2001;3(2):70–8.CrossRefGoogle ScholarPubMed
Bakker, NA, van Imhoff, GW, Verschuuren, EA, van Son, WJ. Presentation and Early Detection of Post-transplant Lymphoproliferative Disorder after Solid Organ Transplantation. Transpl Int. 2007;20(3):207–18.CrossRefGoogle ScholarPubMed
Jamalidoust, M, Geramizadeh, B, Pouladfar, G, Namayandeh, M, Asaie, S, Aliabadi, N, et al. Epstein-Barr Virus DNAemia in Iranian Liver Transplant Recipients and Assessment of Its Variation in Posttransplant Lymphproliferative Disorder Patients by Quantitative Polymerase Chain Reaction Assay. Exp Clin Transplant. 2015;13 Suppl 1:306–11.CrossRefGoogle ScholarPubMed
Randhawa, P, Blakolmer, K, Kashyap, R, Raikow, R, Nalesnik, M, Demetris, AJ, et al. Allograft Liver Biopsy in Patients with Epstein-Barr Virus-associated Posttransplant Lymphoproliferative Disease. Am J Surg Pathol. 2001;25(3):324–30.CrossRefGoogle ScholarPubMed
Loginov, R, Halme, L, Arola, J, Hockerstedt, K, Lautenschlager, I. Intragraft Immunological Events Associated with EBV DNAemia in Liver Transplant Patients. APMIS: acta pathologica, microbiologica, et immunologica Scandinavica. 2010;118(11):888–94.CrossRefGoogle ScholarPubMed
Petrova, M, Kamburov, V. Epstein-Barr Virus: Silent Companion or Causative Agent of Chronic Liver Disease? World Journal of Gastroenterology: WJG. 2010;16(33):4130–4.CrossRefGoogle ScholarPubMed
Harris, N, Swerdlow, S, Frizzera, G, Knowles, D, editors. Post-transplant Lymphoproliferative Disorders. Lyon: IARC Press; 2001.Google Scholar
Singavi, AK, Harrington, AM, Fenske, TS. Post-transplant Lymphoproliferative Disorders. Cancer Treatment and Research. 2015;165:305–27.CrossRefGoogle ScholarPubMed
Hubscher, SG, Williams, A, Davison, SM, Young, LS, Niedobitek, G. Epstein-Barr Virus in Inflammatory Diseases of the Liver and Liver Allografts: An in Situ Hybridization Study. Hepatology. 1994;20(4 Pt 1):899907.CrossRefGoogle ScholarPubMed
Kobayashi, M, Asano, N, Fukushima, M, Honda, T. Three Different Histological Subtypes of Epstein-Barr Virus-negative Post-transplant Lymphoproliferative Disorder in a Patient with Hepatitis C Infection. International Journal of Hematology. 2014;100(3):307–11.CrossRefGoogle Scholar
Morscio, J, Dierickx, D, Ferreiro, JF, Herreman, A, Van Loo, P, Bittoun, E, et al. Gene Expression Profiling Reveals Clear Differences between EBV-positive and EBV-Negative Posttransplant Lymphoproliferative Disorders. Am J Transplant. 2013;13(5):1305–16.CrossRefGoogle ScholarPubMed
Montalbano, M, Slapak-Green, GI, Neff, GW. Fulminant Hepatic Failure from Herpes Simplex Virus: Post Liver Transplantation Acyclovir Therapy and Literature Review. Transplantation Proceedings. 2005;37(10):4393–6.CrossRefGoogle ScholarPubMed
Kusne, S, Schwartz, M, Breinig, MK, Dummer, JS, Lee, RE, Selby, R, et al. Herpes Simplex Virus Hepatitis after Solid Organ Transplantation in Adults. J Infect Dis. 1991;163(5):1001–7.CrossRefGoogle ScholarPubMed
Javed, S, Javed, SA, Tyring, SK. Varicella Vaccines. Current Opinion in Infectious Diseases. 2011.
Lucey, MR, Terrault, N, Ojo, L, Hay, JE, Neuberger, J, Blumberg, E, et al. Long-term Management of the Successful Adult Liver Transplant: 2012 Practice Guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation. Liver Transpl. 2013;19(1):326.CrossRefGoogle Scholar
Basse, G, Mengelle, C, Kamar, N, Ribes, D, Selves, J, Cointault, O, et al. Disseminated Herpes Simplex Type-2 (HSV-2) Infection after Solid-organ Transplantation. Infection. 2008;36(1):62–4.CrossRefGoogle ScholarPubMed
Riediger, C, Sauer, P, Matevossian, E, Muller, MW, Buchler, P, Friess, H. Herpes Simplex Virus Sepsis and Acute Liver Failure. Clinical Transplantation. 2009;23 Suppl 21:3741.CrossRefGoogle ScholarPubMed
Kusne, S, Martin, M, Shapiro, R, Jordan, M, Fung, J, Alessiani, M, et al. Early Infections in Kidney Transplant Recipients under FK 506. Transplantation Proceedings. 1991;23(1 Pt 2):956–7.Google ScholarPubMed
Abdel Massih, RC, Razonable, RR. Human Herpesvirus 6 Infections after Liver Transplantation. World J Gastroenterol. 2009;15(21):2561–9.Google ScholarPubMed
Razonable, RR, Rivero, A, Brown, RA, Hart, GD, Espy, MJ, van Cruijsen, H, et al. Detection of Simultaneous Beta-herpesvirus Infections in Clinical Syndromes due to Defined Cytomegalovirus Infection. Clin Transplant. 2003;17(2):114–20.CrossRefGoogle ScholarPubMed
Lautenschlager, I, Razonable, RR. Human Herpesvirus-6 Infections in Kidney, Liver, Lung, and Heart Transplantation: Review. Transpl Int. 2012;25(5):493502.CrossRefGoogle ScholarPubMed
Lautenschlager, I, Hockerstedt, K, Linnavuori, K, Taskinen, E. Human Herpesvirus-6 Infection after Liver Transplantation. Clin Infect Dis. 1998;26(3):702–7.CrossRefGoogle ScholarPubMed
Lautenschlager, I, Harma, M, Hockerstedt, K, Linnavuori, K, Loginov, R, Taskinen, E. Human Herpesvirus-6 Infection Is Associated with Adhesion Molecule Induction and Lymphocyte Infiltration in Liver Allografts. Journal of Hepatology. 2002;37(5):648–54.CrossRefGoogle ScholarPubMed
Potenza, L, Luppi, M, Barozzi, P, Rossi, G, Cocchi, S, Codeluppi, M, et al. HHV-6A in Syncytial Giant-cell Hepatitis. The New England Journal of Medicine. 2008;359(6):593602.CrossRefGoogle ScholarPubMed
Andreoni, M, Goletti, D, Pezzotti, P, Pozzetto, A, Monini, P, Sarmati, L, et al. Prevalence, Incidence and Correlates of HHV-8/KSHV Infection and Kaposi’s Sarcoma in Renal and Liver Transplant Recipients. J Infect. 2001;43(3):195–9.CrossRefGoogle ScholarPubMed
Pietrosi, G, Vizzini, G, Pipitone, L, Di Martino, G, Minervini, MI, Lo Iacono, G, et al. Primary and Reactivated HHV8 Infection and Disease after Liver Transplantation: A Prospective Study. American Journal of Transplantation: Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 2011;11(12):2715–23.CrossRefGoogle ScholarPubMed
Aseni, P, Vertemati, M, Minola, E, Arcieri, K, Bonacina, E, Camozzi, M, et al. Kaposi’s Sarcoma in Liver Transplant Recipients: Morphological and Clinical Description. Liver Transplantation: Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society. 2001;7(9):816–23.CrossRefGoogle ScholarPubMed
Benhammane, H, Mentha, G, Tschanz, E, El Mesbahi, O, Dietrich, PY. Visceral Kaposi’s Sarcoma Related to Human Herpesvirus-8 in Liver Transplant Recipient: Case Report and Literature Review. Case Reports in Oncological Medicine. 2012;2012:137291.CrossRefGoogle ScholarPubMed
Lebbe, C, Porcher, R, Marcelin, AG, Agbalika, F, Dussaix, E, Samuel, D, et al. Human Herpesvirus 8 (HHV8) Transmission and Related Morbidity in Organ Recipients. Am J Transplant. 2013;13(1):207–13.CrossRefGoogle ScholarPubMed
Pozo, F, Tenorio, A, de la Mata, M, de Ory, F, Torre-Cisneros, J. Persistent Human Herpesvirus 8 Viremia before Kaposi’s Sarcoma Development in a Liver Transplant Recipient. Transplantation. 2000;70(2):395–7.CrossRefGoogle Scholar
Koneru, B, Jaffe, R, Esquivel, CO, Kunz, R, Todo, S, Iwatsuki, S, et al. Adenoviral Infections in Pediatric Liver Transplant Recipients. Jama. 1987;258(4):489–92.CrossRefGoogle ScholarPubMed
Michaels, MG, Green, M, Wald, ER, Starzl, TE. Adenovirus Infection in Pediatric Liver Transplant Recipients. J Infect Dis. 1992;165(1):170–4.CrossRefGoogle ScholarPubMed
Saad, RS, Demetris, AJ, Lee, RG, Kusne, S, Randhawa, PS. Adenovirus Hepatitis in the Adult Allograft Liver. Transplantation. 1997;64(10):1483–5.CrossRefGoogle ScholarPubMed
Perez, D, McCormack, L, Petrowsky, H, Jochum, W, Mullhaupt, B, Clavien, PA. Successful Outcome of Severe Adenovirus Hepatitis of the Allograft Following Liver Transplantation. Transplant Infectious Disease: An Official Journal of the Transplantation Society. 2007;9(4):318–22.CrossRefGoogle ScholarPubMed
Hoffman, JA. Adenoviral Disease in Pediatric Solid Organ Transplant Recipients. Pediatric Transplantation. 2006;10(1):1725.CrossRefGoogle ScholarPubMed
Kerensky, T, Hasan, A, Schain, D, Trikha, G, Liu, C, Rand, K, et al. Histopathologic Resolution of Adult Liver Transplantation Adenovirus Hepatitis with Cidofovir and Intravenous Immunoglobulin: A Case Report. Transplantation Proceedings. 2013;45(1):293–6.CrossRefGoogle ScholarPubMed
Ronan, BA, Agrwal, N, Carey, EJ, De Petris, G, Kusne, S, Seville, MT, et al. Fulminant Hepatitis due to Human Adenovirus. Infection. 2014;42(1):105–11.CrossRefGoogle ScholarPubMed
Cimsit, B, Tichy, EM, Patel, SB, Rosencrantz, R, Emre, S. Treatment of Adenovirus Hepatitis with Cidofovir in a Pediatric Liver Transplant Recipient. Pediatr Transplant. 2012;16(3):E903.CrossRefGoogle Scholar
McGrath, D, Falagas, ME, Freeman, R, Rohrer, R, Fairchild, R, Colbach, C, et al. Adenovirus Infection in Adult Orthotopic Liver Transplant Recipients: Incidence and Clinical Significance. J Infect Dis. 1998;177(2):459–62.CrossRefGoogle ScholarPubMed
Ohori, NP, Michaels, MG, Jaffe, R, Williams, P, Yousem, SA. Adenovirus Pneumonia in Lung Transplant Recipients. Hum Pathol. 1995;26(10):1073–9.CrossRefGoogle ScholarPubMed
Zarrinpar, A, Kaldas, F, Busuttil, RW. Liver Transplantation for Hepatocellular Carcinoma: An Update. Hepatobiliary & Pancreatic Diseases International: HBPD INT. 2011;10(3):234–42.CrossRefGoogle ScholarPubMed
Washburn, K, Halff, G. Hepatocellular Carcinoma and Liver Transplantation. Curr Opin Organ Transplant. 2011;16(3):297300.CrossRefGoogle ScholarPubMed
Chok, K. Management of Recurrent Hepatocellular Carcinoma after Liver Transplant. World J Hepatol. 2015;7(8):1142–8.CrossRefGoogle ScholarPubMed
Schmeding, M, Neumann, UP. Liver Transplant for Cholangiocarcinoma: A Comeback? Exp Clin Transplant. 2015;13(4):301–8.Google ScholarPubMed
Grossman, EJ, Millis, JM. Liver Transplantation for Non-hepatocellular Carcinoma Malignancy: Indications, Limitations, and Analysis of the Current Literature. Liver Transplantation: Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society. 2010;16(8):930–42.CrossRefGoogle ScholarPubMed
Hunt, J, Gordon, FD, Jenkins, RL, Lewis, WD, Khettry, U. Sarcoidosis with Selective Involvement of a Second Liver Allograft: Report of a Case and Review of the Literature. Mod Pathol. 1999;12(3):325–8.Google ScholarPubMed
Vanatta, JM, Modanlou, KA, Dean, AG, Nezakatgoo, N, Campos, L, Nair, S, et al. Outcomes of Orthotopic Liver Transplantation for Hepatic Sarcoidosis: An Analysis of the United Network for Organ Sharing/Organ Procurement and Transplantation Network Data Files for a Comparative Study with Cholestatic Liver Diseases. Liver Transplantation: Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society. 2011;17(9):1027–34.Google ScholarPubMed
Pappo, O, Yunis, E, Jordan, JA, Jaffe, R, Mateo, R, Fung, J, et al. Recurrent and de Novo Giant Cell Hepatitis after Orthotopic Liver Transplantation. Am J Surg Pathol. 1994;18(8):804–13.CrossRefGoogle ScholarPubMed
Starzl, TE, Demetris, AJ. Liver Transplantation: A 31-year Perspective. Part I. Curr Probl Surg. 1990;27(2):55116.CrossRefGoogle ScholarPubMed
Starzl, TE, Demetris, AJ. Liver Transplantation: A 31-year Perspective. Part II. Curr Probl Surg. 1990;27(3):123–78.Google ScholarPubMed
Starzl, TE, Demetris, AJ. Liver Transplantation: A 31-year Perspective. Part III. Curr Probl Surg. 1990;27(4):187240.CrossRefGoogle ScholarPubMed
Huang, J. Ethical and Legislative Perspectives on Liver Transplantation in the People’s Republic of China. Liver Transpl. 2007;13(2):193–6.CrossRefGoogle ScholarPubMed
Saab, S, Greenberg, A, Li, E, Bau, SN, Durazo, F, El-Kabany, M, et al. Sofosbuvir and Simeprevir Is Effective for Recurrent Hepatitis C in Liver Transplant Recipients. Liver International: Official Journal of the International Association for the Study of the Liver. 2015.
Coilly, A, Roche, B, Duclos-Vallee, JC, Samuel, D. Optimal Therapy in Hepatitis C Virus Liver Transplant Patients with Direct Acting Antivirals. Liver International: Official Journal of the International Association for the Study of the Liver. 2015;35 Suppl 1:4450.CrossRefGoogle ScholarPubMed
Cavallari, A, De Raffele, E, Bellusci, R, Miniero, R, Vivarelli, M, Galli, S, et al. De Novo Hepatitis B and C Viral Infection after Liver Transplantation. World J Surg. 1997;21(1):7884.CrossRefGoogle Scholar
Jimenez-Perez, M, Gonzalez-Grande, R, Rando-Munoz, FJ. Management of Recurrent Hepatitis C Virus after Liver Transplantation. World J Gastroenterol. 2014;20(44):16409–17.CrossRefGoogle ScholarPubMed
Laverdure, N, Scholtes-Brunel, C, Rivet, C, Heissat, S, Restier, L, Bacchetta, J, et al. Paediatric Liver Transplanted Patients and Prevalence of Hepatitis E Virus. Journal of Clinical Virology: The Official Publication of the Pan American Society for Clinical Virology. 2015;69:22–6.CrossRefGoogle ScholarPubMed
Eisenbach, C, Longerich, T, Fickenscher, H, Schalasta, G, Stremmel, W, Encke, J. Recurrence of Clinically Significant Hepatitis A Following Liver Transplantation for Fulminant Hepatitis A. Journal of Clinical Virology: The Official Publication of the Pan American Society for Clinical Virology. 2006;35(1):109–12.CrossRefGoogle ScholarPubMed
Park, GC, Hwang, S, Yu, YD, Park, PJ, Choi, YI, Song, GW, et al. Intractable Recurrent Hepatitis A Virus Infection Requiring Repeated Liver Transplantation: A Case Report. Transplantation Proceedings. 2010;42(10):4658–60.CrossRefGoogle ScholarPubMed
Gane, E, Sallie, R, Saleh, M, Portmann, B, Williams, R. Clinical Recurrence of Hepatitis A Following Liver Transplantation for Acute Liver Failure. J Med Virol. 1995;45(1):35–9.CrossRefGoogle ScholarPubMed
Fagan, E, Yousef, G, Brahm, J, Garelick, H, Mann, G, Wolstenholme, A, et al. Persistence of Hepatitis A Virus in Fulminant Hepatitis and after Liver Transplantation. J Med Virol. 1990;30(2):131–6.CrossRefGoogle ScholarPubMed
Liu, J, Zhang, S, Wang, Q, Shen, H, Zhang, M, Zhang, Y, et al. Seroepidemiology of Hepatitis B Virus Infection in 2 Million Men Aged 21–49 Years in Rural China: A Population-based, Cross-sectional Study. The Lancet Infectious Diseases. 2015.
Zhang, W, Ji, Z, Wang, L, Xiao, D, Yan, Y. A Meta-analysis of HBsAg-positive Rate among General Chinese Populations Aged 1–59 Years. Infectious Diseases (London, England). 2015:1–11.
Samuel, D, Muller, R, Alexander, G, Fassati, L, Ducot, B, Benhamou, JP, et al. Liver Transplantation in European Patients with the Hepatitis B Surface Antigen. The New England Journal of Medicine. 1993;329(25):1842–7.CrossRefGoogle ScholarPubMed
Jiang, L, Yan, LN. Current Therapeutic Strategies for Recurrent Hepatitis B Virus Infection after Liver Transplantation. World Journal of Gastroenterology: WJG. 2010;16(20):2468–75.CrossRefGoogle ScholarPubMed
Chen, J, Yi, L, Jia, JD, Ma, H, You, H. Hepatitis B Immunoglobulins and/or Lamivudine for Preventing Hepatitis B Recurrence after Liver Transplantation: A Systematic Review. J Gastroenterol Hepatol. 2010;25(5):872–9.CrossRefGoogle ScholarPubMed
Fung, J, Lo, R, Chan, SC, Chok, K, Wong, T, Sharr, W, et al. Outcomes Including Liver Histology after Liver Transplantation for Chronic Hepatitis B Using Oral Antiviral Therapy Alone. Liver Transpl. 2015.
Wesdorp, DJ, Knoester, M, Braat, AE, Coenraad, MJ, Vossen, AC, Claas, EC, et al. Nucleoside Plus Nucleotide Analogs and Cessation of Hepatitis B Immunoglobulin after Liver Transplantation in Chronic Hepatitis B Is Safe and Effective. Journal of Clinical Virology: The Official Publication of the Pan American Society for Clinical Virology. 2013;58(1):6773.CrossRefGoogle ScholarPubMed
Yurdaydin, C, Idilman, R. Therapy of Delta Hepatitis. Cold Spring Harbor Perspectives in Medicine. 2015.
Pascarella, S, Negro, F. Hepatitis D Virus: An Update. Liver International: Official Journal of the International Association for the Study of the Liver. 2011;31(1):721.CrossRefGoogle ScholarPubMed
Govindarajan, S, De Cock, KM, Redeker, AG. Natural Course of Delta Superinfection in Chronic Hepatitis B Virus-infected Patients: Histopathologic Study with Multiple Liver Biopsies. Hepatology. 1986;6(4):640–4.CrossRefGoogle ScholarPubMed
Roche, B, Samuel, D. Liver Transplantation in Delta Virus Infection. Seminars in Liver Disease. 2012;32(3):245–55.Google ScholarPubMed
Demetris, AJ, Jaffe, R, Sheahan, DG, Burnham, J, Spero, J, Iwatsuki, S, et al. Recurrent Hepatitis B in Liver Allograft Recipients. Differentiation between Viral Hepatitis B and Rejection. Am J Pathol. 1986;125(1):161–72.Google ScholarPubMed
Demetris, AJ, Todo, S, Van Thiel, DH, Fung, JJ, Iwaki, Y, Sysyn, G, et al. Evolution of Hepatitis B Virus Liver Disease after Hepatic Replacement. Practical and Theoretical Considerations. Am J Pathol. 1990;137(3):667–76.Google ScholarPubMed
Zhang, X, Xiang, C, Zhou, YH, Jiang, A, Qin, YY, He, J. Effect of Statins on Cardiovascular Events in Patients with Mild to Moderate Chronic Kidney Disease: A Systematic Review and Meta-analysis of Randomized Clinical Trials. BMC Cardiovasc Disord. 2014;14:19.CrossRefGoogle ScholarPubMed
Roche, B, Samuel, D. The Difficulties of Managing Severe Hepatitis B Virus Reactivation. Liver International: Official Journal of the International Association for the Study of the Liver. 2011;31 Suppl 1:104–10.CrossRefGoogle ScholarPubMed
Harrison, RF, Davies, MH, Goldin, RD, Hubscher, SG. Recurrent Hepatitis B in Liver Allografts: A Distinctive Form of Rapidly Developing Cirrhosis. Histopathology. 1993;23(1):21–8.CrossRefGoogle ScholarPubMed
Thung, SN. Histologic Findings in Recurrent HBV. Liver Transpl. 2006;12(11 Suppl 2):S503.CrossRefGoogle ScholarPubMed
Davies, SE, Portmann, BC, O’Grady, JG, Aldis, PM, Chaggar, K, Alexander, GJ, et al. Hepatic Histological Findings after Transplantation for Chronic Hepatitis B Virus Infection, Including a Unique Pattern of Fibrosing Cholestatic Hepatitis. Hepatology. 1991;13(1):150–7.CrossRefGoogle ScholarPubMed
O’Grady, JG, Smith, HM, Davies, SE, Daniels, HM, Donaldson, PT, Tan, KC, et al. Hepatitis B Virus Reinfection after Orthotopic Liver Transplantation. Serological and Clinical Implications. Journal of Hepatology. 1992;14(1):104–11.Google ScholarPubMed
Yurdaydin, C, Idilman, R, Bozkaya, H, Bozdayi, AM. Natural History and Treatment of Chronic Delta Hepatitis. J Viral Hepat. 2010;17(11):749–56.CrossRefGoogle ScholarPubMed
Salomao, M, Verna, EC, Lefkowitch, JH, Moreira, RK. Histopathologic Distinction between Fibrosing Cholestatic Hepatitis C and Biliary Obstruction. The American Journal of Surgical Pathology. 2013;37(12):1837–44.CrossRefGoogle ScholarPubMed
Verna, EC. Hepatitis Viruses and Liver Transplantation: Evolving Trends in Antiviral Management. Clin Liver Dis. 2014;18(3):575601.CrossRefGoogle ScholarPubMed
Verna, EC, O’Leary, JG. Hepatitis C Treatment in Patients on the Liver Transplant Waiting List. Curr Opin Organ Transplant. 2015;20(3):242–50.CrossRefGoogle ScholarPubMed
Gane, EJ. The Natural History of Recurrent Hepatitis C and What Influences This. Liver Transpl. 2008;14 Suppl 2:S3644.CrossRefGoogle Scholar
Ramirez, S, Perez-Del-Pulgar, S, Forns, X. Virology and Pathogenesis of Hepatitis C Virus Recurrence. Liver Transpl. 2008;14 Suppl 2:S2735.CrossRefGoogle ScholarPubMed
McCaughan, GW, Shackel, NA, Bertolino, P, Bowen, DG. Molecular and Cellular Aspects of Hepatitis C Virus Reinfection after Liver Transplantation: How the Early Phase Impacts on Outcomes. Transplantation. 2009;87(8):1105–11.CrossRefGoogle ScholarPubMed
Verna, EC, Abdelmessih, R, Salomao, MA, Lefkowitch, J, Moreira, RK, Brown, RS Jr. Cholestatic Hepatitis C Following Liver Transplantation: An Outcome-based Histological Definition, Clinical Predictors, and Prognosis. Liver Transpl. 2013;19(1):7888.CrossRefGoogle ScholarPubMed
Berenguer, M, Aguilera, V, Prieto, M, San Juan, F, Rayon, JM, Benlloch, S, et al. Significant Improvement in the Outcome of HCV-infected Transplant Recipients by Avoiding Rapid Steroid Tapering and Potent Induction Immunosuppression. Journal of Hepatology. 2006;44(4):717–22.CrossRefGoogle ScholarPubMed
Marcos, A, Eghtesad, B, Fung, JJ, Fontes, P, Patel, K, Devera, M, et al. Use of Alemtuzumab and Tacrolimus Monotherapy for Cadaveric Liver Transplantation: With Particular Reference to Hepatitis C Virus. Transplantation. 2004;78(7):966–71.CrossRefGoogle ScholarPubMed
Eghtesad, B, Fung, JJ, Demetris, AJ, Murase, N, Ness, R, Bass, DC, et al. Immunosuppression for Liver Transplantation in HCV-infected Patients: Mechanism-based Principles. Liver Transpl. 2005;11(11):1343–52.CrossRefGoogle ScholarPubMed
Thursz, M, Yee, L, Khakoo, S. Understanding the Host Genetics of Chronic Hepatitis B and C. Seminars in Liver Disease. 2011;31(2):115–27.CrossRefGoogle ScholarPubMed
Charlton, MR, Thompson, A, Veldt, BJ, Watt, K, Tillmann, H, Poterucha, JJ, et al. Interleukin-28B Polymorphisms Are Associated with Histological Recurrence and Treatment Response Following Liver Transplantation in Patients with Hepatitis C Virus Infection. Hepatology. 2011;53(1):317–24.CrossRefGoogle ScholarPubMed
Fukuhara, T, Taketomi, A, Motomura, T, Okano, S, Ninomiya, A, Abe, T, et al. Variants in IL28B in Liver Recipients and Donors Correlate with Response to Peg-Interferon and Ribavirin Therapy for Recurrent Hepatitis C. Gastroenterology. 2010;139(5):1577–85, 85 e1–3.CrossRefGoogle ScholarPubMed
Demetris, AJ. Evolution of Hepatitis C Virus in Liver Allografts. Liver Transpl. 2009;15 Suppl 2:S3541.CrossRefGoogle ScholarPubMed
Chhatwal, J, Kanwal, F, Roberts, MS, Dunn, MA. Cost-effectiveness and Budget Impact of Hepatitis C Virus Treatment with Sofosbuvir and Ledipasvir in the United States. Ann Intern Med. 2015;162(6):397406.CrossRefGoogle ScholarPubMed
Berenguer, M. Natural History of Recurrent Hepatitis C. Liver Transpl. 2002;8(10 Suppl 1):S148.CrossRefGoogle ScholarPubMed
Berenguer, M, Aguilera, V, Prieto, M, Carrasco, D, Rayon, M, San Juan, F, et al. Delayed Onset of Severe Hepatitis C-related Liver Damage Following Liver Transplantation: A Matter of Concern? Liver Transpl. 2003;9(11):1152–8.CrossRefGoogle ScholarPubMed
Dhanasekaran, R, Sanchez, W, Mounajjed, T, Wiesner, RH, Watt, KD, Charlton, MR. Impact of Fibrosis Progression on Clinical Outcome in Patients Treated for Post-transplant Hepatitis C Recurrence. Liver International: Official Journal of the International Association for the Study of the Liver. 2015.
Burton, JR Jr., Rosen, HR. Acute Rejection in HCV-infected Liver Transplant Recipients: The Great Conundrum. Liver Transpl. 2006;12(11 Suppl 2):S3847.CrossRefGoogle ScholarPubMed
Moreira, RK. Recurrent Hepatitis C and Acute Allograft Rejection: Clinicopathologic Features with Emphasis on the Differential Diagnosis between These Entities. Advances in Anatomic Pathology. 2011;18(5):393405.CrossRefGoogle ScholarPubMed
Asanza, CG, Garcia-Monzon, C, Clemente, G, Salcedo, M, Garcia-Buey, L, Garcia-Iglesias, C, et al. Immunohistochemical Evidence of Immunopathogenetic Mechanisms in Chronic Hepatitis C Recurrence after Liver Transplantation. Hepatology. 1997;26(3):755–63.CrossRefGoogle ScholarPubMed
Rosen, HR, Martin, P. Hepatitis, C Infection in Patients Undergoing Liver Retransplantation. Transplantation. 1998;66(12):1612–6.CrossRefGoogle ScholarPubMed
Rosen, HR, Martin, P, Goss, J, Donovan, J, Melinek, J, Rudich, S, et al. Significance of Early Aminotransferase Elevation after Liver Transplantation. Transplantation. 1998;65(1):6872.CrossRefGoogle ScholarPubMed
Ferrell, LD, Wright, TL, Roberts, J, Ascher, N, Lake, J. Hepatitis C Viral Infection in Liver Transplant Recipients. Hepatology. 1992;16(4):865–76.CrossRefGoogle ScholarPubMed
Demetris, AJ, Sebagh, M. Plasma Cell Hepatitis in Liver Allografts: Variant of Rejection or Autoimmune Hepatitis? Liver Transpl. 2008;14(6):750–5.CrossRefGoogle ScholarPubMed
Guido, M, Burra, P. De Novo Autoimmune Hepatitis after Liver Transplantation. Seminars in Liver Disease. 2011;31(1):7181.CrossRefGoogle ScholarPubMed
Castillo-Rama, M, Sebagh, M, Sasatomi, E, Randhawa, P, Isse, K, Salgarkar, AD, et al. “Plasma Cell Hepatitis” in Liver Allografts: Identification and Characterization of an IgG4-Rich Cohort. Am J Transplant. 2013;13(11):2966–77.CrossRefGoogle ScholarPubMed
Fiel, MI, Agarwal, K, Stanca, C, Elhajj, N, Kontorinis, N, Thung, SN, et al. Posttransplant Plasma Cell Hepatitis (de Novo Autoimmune Hepatitis) Is a Variant of Rejection and May Lead to a Negative Outcome in Patients with Hepatitis C Virus. Liver Transpl. 2008;14(6):861–71.CrossRefGoogle ScholarPubMed
Berardi, S, Lodato, F, Gramenzi, A, D’Errico, A, Lenzi, M, Bontadini, A, et al. High Incidence of Allograft Dysfunction in Liver Transplanted Patients Treated with Pegylated-interferon Alpha-2b and Ribavirin for Hepatitis C Recurrence: Possible de Novo Autoimmune Hepatitis? Gut. 2007;56(2):237–42.CrossRefGoogle ScholarPubMed
Alvarez, F, Berg, PA, Bianchi, FB, Bianchi, L, Burroughs, AK, Cancado, EL, et al. International Autoimmune Hepatitis Group Report: Review of Criteria for Diagnosis of Autoimmune Hepatitis. Journal of Hepatology. 1999;31(5):929–38.CrossRefGoogle ScholarPubMed
Czaja, AJ, Carpenter, HA. Sensitivity, Specificity, and Predictability of Biopsy Interpretations in Chronic Hepatitis. Gastroenterology. 1993;105(6):1824–32.CrossRefGoogle ScholarPubMed
Czaja, AJ, Carpenter, HA. Histological Findings in Chronic Hepatitis C with Autoimmune Features. Hepatology. 1997;26(2):459–66.CrossRef